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Abstract 
 
Previous attempts to control cellular behavior were mainly based on genetic engineering. 
While useful, such an approach suffers from several complications. Living cells grow and evolve 
which could lead to modifications of the engineered circuits, causing not only the loss of their 
functions but also an altering of the environment. However, other methods are possible. All living 
cells can naturally sense and respond to their environment and to each other. Thus, artificial, non-
living cells can be engineered to activate already existing natural cellular pathways. In this way, the 
genetic engineering component moves from the natural to completely artificial, laboratory-made 
cells. Moreover, synthetic systems operating in living organisms also depend on elements with 
unknown function, leaving many gaps in the understanding of how living cells work. Building life-
like systems with non-living components could help reveal unrecognized but necessary cellular 
mechanisms. However, the design of functional, genetically encoded cell-free systems is difficult, 
because biological parts have been evolved to function optimally inside of living cells. In vitro 
conditions are different.   
First, some practical rules for the construction of functional synthetic circuits in vitro were 
defined. The Influences of the organization of genetic elements within a synthetic operon on 
protein expression levels were studied and optimal sequence compositions and lengths between 
genes to assemble genetic circuits were found. Then, artificial cells that can control the behavior of 
living systems were built. The artificial cells were able to sense a molecule that Escherichia coli 
cannot sense on its own and translate that molecule into a chemical message that E. coli can 
sense and respond to. The natural sensing of E. coli was expanded without genetically modifying 
the bacteria. Finally, to better integrate artificial with natural cells, a complete communication 
pathway was constructed. Bacteria speak to each other by quorum sensing. Such mechanisms 
mediate cell-cell communication among bacteria and regulate several cell density related 
processes, such as virulence. Various synthetic quorum sensing mechanisms were constructed in 
vitro within artificial cells. Artificial cells able to sense the presence of living cells were built. In 
addition, the artificial cells were capable to synthesize quorum sensing molecules for E. coli, Vibrio 
harveyi, Vibrio fischeri and Pseudomonas aeruginosa. When integrated together, artificial cells 
successfully mediated interspecies communication with natural cells. Such artificial systems could 
be useful as therapeutic tools to defeat pathogenic infections. Moreover, the achievement of such 
functions represents a new way to better understand the potential of the artificial cells to mimic 
cellular life.  
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Abbreviation list  
 
3OC4 HSL = 3-oxo-N-(2-oxotetrahydrofuran-3-yl)butanamide 
3OC6 HSL = N-3-(oxohexanoyl) homoserine lactone  
3OC12 HSL = N-(3-oxododecanoyl)-l- homoserine lactone 
32P-ATP = 32P- alpha adenosine triphosphate 
ACP = acyl carrier protein 
αHL  =  alpha-hemolysin 
AHLs = acyl homoserine lactones 
AI-2 = autoinducer 2 
C4 HSL = N-butanoyl-l-homoserine 
C8 HSL = N-octanoyl-L-Homoserine lactone 
CRP = cAMP receptor protein 
DOPG = 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) 
DPD = 4,5- dihydroxy- 2,3- pentanedione 
DSPE = 1,2-distearoyl-sn-glycero-3-phosphoethanolamine 
DTNB = 2,2'-dinitro-5,5'-ditiodibenzoico 
DTT = dithiothreitol 
FACS = fluorescence-activated cell sorting  
HLPT = His-LuxS-Pfs-Tyr 
IPTG = isopropyl ß-D-1-thiogalactopyranoside 
PCR = polymerase chain reaction 
PE = phosphatidylethanolamine 
PEG = polyethylene glycol 
PG = phosphatidylglycerol 
POPC = 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
QS = quorum sensing 
RBS = ribosome binding site 
RT-qPCR = reverse transcription quantitative PCR  
SAH = S-adenosylhomocysteine 
SAM = S-adenosylmethionine 
SRH = S-ribosylhomocysteine 
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The main approach used in synthetic biology relies on the construction of new behavior 
within already existing cells through genetic engineering. Living cells are genetically modified to 
accomplish specific tasks. For example, biological parts are assembled in predictable systems and 
inserted in natural cells building organisms that can detect pollutants2 or produce 
pharmaceuticals3. A large variety of standardized biological parts are now available4, 5 to create 
new complex genetic circuits within living cells6, 7. Several studies show engineered bacteria which 
could be used as a diagnostic tool8, for both the prevention and treatment of different diseases. For 
example, programmed bacteria are able to recognize and invade cancer cells9 or to act as 
biosensors to sense and report exposures to chemicals10. In this view, the engineered bacteria will 
be applied to the patients. However, the control of living cellular behavior through genetic 
intervention could lead to various complications. Engineered pathways have to be stable also in 
complex environments different from the controlled conditions found in the laboratory. Living 
systems grow and evolve which could lead to the modification of the engineered circuits, causing 
not only the loss of their functions but also to the altering of the environment. To avoid such 
complications, the genetically engineered parts could be moved from the natural cells to artificial, 
laboratory-made cells. Artificial cells can be made to only contain the elements needed for a 
specific task and disappear from the environment once that task has been accomplished. 
Moreover, the construction of new biological function could lead to significant advances to 
the knowledge of how life works. However, synthetic systems operating in living organisms also 
depend on elements with unknown function, leaving many gaps in the understanding of how living 
cells work. Building life starting from scratch, using non-living components will bring to a better 
understanding and help to move from traditional engineering. There is no clear definition of life and 
no defined criteria to describe what is alive. Thus, efforts are made in imitate something that 
resembles extant cells and in mimicking some common features of living systems11, 12.  
 
1.1 Reconstructing the parts and organization of life  
Cellular mimics are typically constructed from the same building blocks as natural living 
cells, (Fig. 1.1) including a compartment of some type to distinguish the cell from the surrounding 
environment, nucleic acids to store genetic information, and some type of machinery to synthesize 
proteins. Each part can be functionally produced in the laboratory. The construction of the 
compartment can be easily achieved since lipids spontaneously assemble in aqueous solutions 
forming vesicles. Non-lipid defined compartments can be made with nonbiological polymers and 
proteins13. Transcription and translation can be carried out in vitro with reconstituted systems made 
from purified components14 or from cell extracts15. Moreover, protein synthesis is amenable to the 
conditions inside of a vesicle16.  




Fig. 1.1 Minimal components of artificial cells. 
Artificial cells often comprise a compartment made of lipids to separate the inside from the outside, DNA or 
RNA to store genetic information and transcription-translation machinery to synthesize proteins (adapted 
from Forlin et al.1).   
 
To further organize the interior of the artificial cells, polymers, such as dextran and 
polyethylene glycol, can be added to form distinct aqueous phases17 in which molecules can 
preferentially partition. Aqueous phase separation mimics the segregation properties of 
intracellular organelles inside of living cells. In fact, aqueous phase separated systems are 
compatible with protein synthesis18 resulting in preferential partitioning of the hydrophilic proteins to 
the dextran rich phase. However, recent studies suggest an inability of aqueous phase separated 
systems to efficiently segregate RNA molecules19. Vesicle organization can also be improved by 
reconstructing a cytoskeleton20 with bacterially derived cytoskeletal elements that self-assemble 
into filamentous structures within phospholipid membranes21. Such structures can also be used to 
drive shape changes. For example, actin filaments anchored to liposome membranes22 contract 
upon the addition of myosin23. 
  The construction of something that physically looks like a cell is not enough to be 
perceived as a living cell. Living organisms are able to reproduce, evolve, communicate with the 
external environment, move and adapt. So far, most of the effort put into mimicking cellular life has 
been on replication and evolution, although a few studies have explored other features of life.  
 
1.2 Artificial reproduction  
 Cellular mimics need a way to replicate their genetic information and their compartment. 
One fundamental cellular function is represented by replication. While DNA replication in vitro is 
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easy, the reconstruction of the replication system of a cell is challenging. Bacterial isothermal DNA 
replication machinery based on thermophilic helicase is able to replicate DNA when encapsulated 
inside phospholipid vesicles24. Moreover, a four protein based replication system based on phage 
Phi29 allows for the replication of the entire viral genome in vitro25 26. To reduce the amount of 
elements needed for replication, RNA based systems were constructed inside vesicles in a way 
that the RNA molecule acts as a template both for replication and protein synthesis27. Moreover, 
such systems presented the ability to evolve, while performing long-term replication errors are 
introduced and highly replicable mutants prevailed over the population, following Darwinian 
evolution28.    
It may be possible to simplify cellular mimics by removing the dependence upon proteins, 
and instead exploit RNA catalytic activity. RNA polymerase ribozymes functionally replicate a wide 
range of RNAs sequences29 and even catalyze the accurate synthesis of RNA sequences longer 
than themself30. Perhaps it will eventually be possible to fully replicate genomes with a replicase 
ribozyme in the absence of proteins. Alternatively, replication could be further simplified by 
removing the catalyst all together. For example, imidazole activated-nucleotides can diffuse into 
fatty acids vesicles and mediate template-directed polymerization31 32.  
Several advancements in in vitro vesicle replication were made. Vesicle budding and 
division were achieved without proteins due to the presence of different lipid micro domains and 
the application of osmotic pressure33. In addition, systems encapsulating two different aqueous 
phases were able to undergo one cycle of division34. While when both mechanisms were joined 
together, even daughter vesicles maintained the correct asymmetry needed to divide35. Vesicles 
composed by phospholipids and fatty acids have the capacity to grow into unstable filaments that 
then split apart with slight mechanical agitation36 or through internal chemical mechanisms 
dependent  on thiol oxidation-reduction reactions37. 
It is also possible to divide vesicles based on the activity of proteins. Recent studies focus 
on the reconstruction in vitro of minimal cell division machinery38 composed of the elements 
necessary for the generation of a constriction force. In particular, FtsZ forms in vivo a constriction 
ring, the Z ring, together with other proteins that eventually leads to cell division. When inserted 
within liposomes, an engineered FtsZ is able to reach the membrane and form multiple Z rings that 
exert constriction in vesicles39 but are not able to divide the lipid compartment. The incorporation of 
the partner protein FtsA that helps mediate interactions between FtsZ and the lipid membrane 
apparently leads to complete liposome scission40. Another key division element is the Min protein 
system that oscillates in vivo along the bacterial cell to select the division site in the center of the 
cell. In vitro reconstitutions form waves on flat membranes41, 42 and oscillate in vitro in synthetic 
systems mimicking bacterial cell shape43. When integrated in a single in vitro system, Min proteins 
 9  
form a gradient that targets FtsZ to the middle of the cell-like compartment, regulating the 
localization of the protein44. 
Sugawara developed instead an alternative method for vesicles division dependent upon 
intravesicular DNA replication. By coupling two different fundamental processes plus a few specific 
membrane interacting molecules, the replication of DNA through PCR inside the lipid compartment 
lead to ionic interactions between the DNA and the membrane resulting in the division of the 
vesicle45.  
 
1.3 Life-like behavior 
Several advances were made in the construction in vitro of cellular division, organization 
and replication. However, such features are not enough to perceive artificial cells as living. Natural 
cells sense and respond to their internal and external environment. Recent studies show a step 
forward through the construction of in vitro sense-response systems with the development of 
several sensing pathways. Synthetic genetic circuits can be used in vitro to sense small molecules, 
such as IPTG, and activate or repress different pathways46. Multiple step cascades47, logic gates 
and feedback loops48 can be implemented in cell-free systems and controlled by the availability of 
small molecules. In addition, in vitro systems were built to sense molecules secreted from living 
cells, such as bacterial homoserine lactones, that can be used to activate gene expression49. 
Communication with the external environment can be established through the diffusion of 
activators and repressors among connected silicon compartments50.  
Other than proteins, in vitro transcription and translation can be controlled by RNA 
regulatory elements, such as riboswitches51. Riboswitches reside in the untranslated region of 
mRNA and act as transcriptional or translational controlled elements, changing their conformation 
upon the binding of specific molecules and in response regulating protein expression. Such 
regulatory elements can be exploited within artificial cells to build systems able to sense the 
external environment. For example, a theophylline riboswitch functionally can control protein 
production inside of phospholipid vesicles52.  
In addition, non-genetically encoded sensing mechanisms are possible. In two aqueous 
phase systems, proteins localization can change in response to pH fluctuations53 and chemical 
systems can move towards food molecules54.  
The formation of pores into the lipid membrane allows the continuous exchange of nutrients 
between the inside and the outside of the artificial cells55. Not only can energy sources be 
exchanged between the artificial cells and their surroundings, but also small molecules can 
traverse the membrane, which could be exploited to send chemical messages to living systems. 
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Autoinducers, small molecules naturally secreted from bacteria, can be synthesized within vesicles 
and can escape through pores to bacterial cells56. Pore forming protein activity in artificial systems 
can be also increased through in vitro evolution performed directly inside liposomes to generate 
highly functional membrane proteins57. 
The capacity to sense the external environment, elaborate the information and send an 
output to the outside can be unified in a single artificial system. This could lead to an encapsulated, 
artificial system that senses a chemical secreted by living cells, the synthesis of a new signaling 
molecule inside the vesicle in response to the sensed signal, release of the newly synthesized 
molecule, and finally detection by natural cells58.     
 
1.4 Conclusion 
Artificial cells able to sense and respond to their surroundings could better represent the 
complexities of life and may come closer to being perceived as living. Pursuing this approach, it 
will be possible to construct artificial systems that are better integrated with natural cells. The 
achievement of such functions could be useful to better understand the potential of the artificial 
cells to mimic cellular life. Although several life-like behaviors were successfully reconstructed in 
vitro, there is not a clear idea of what to build if the goal is to build a living cell. This is partly 
because there is no agreed upon definition of life. The result has been a somewhat subjective 
evaluation of artificial cells in terms of their relatedness to known living systems. One path forward 
that could potentially remove such obstacles would be to construct artificial cells with the ability to 
perceive the presence of living organisms and in response send chemical messages to the 
organism. Since, in this case, the artificial cell would be engaging the natural cell in a manner 
analogous to another natural cell, the ability of the natural cell to distinguish between the two can 
be evaluated. The evaluation of the life-like properties of the artificial cell would, therefore, be 
moved from us, the observers, to natural cells. Similar to that described by Turing to evaluate the 
intelligence of a machine59, natural cells interacting with artificial cells could be used to evaluate 
how life-like the cellular mimic are without conclusively passing judgment on whether something is 
actually alive or not60. In other words, a useful metric would become available that could help push 
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This chapter has been adapted from: 
Fluorescent proteins and in vitro genetic organization for cell-free synthetic biology 61 
Roberta Lentini, Michele Forlin, Laura Martini, Cristina Del Bianco, Amy C. Spencer, 
Domenica Torino and Sheref S. Mansy 
 
ACS Synthetic Biology, 2013, 2, 482-9 
 
Attached at the end of the chapter. Supporting information attached in the appendix. 
Reprinted with the permission of the copyright holder  
American Chemical Society 
 
My contribution to this work concerns the design, cloning and mutagenesis of the genetic 
constructs, the setting and collecting of all the experimental measurements, manuscript writing and 
editing.  
 19  
Many efforts were made in the standardization of biological parts finding methods to identify 
and characterize various genetic elements. For example, a set of standard biological parts is now 
available in the registry of standard biological parts62. However these parts are manly 
characterized in living organisms, and synthetic regulatory networks are well studied in vivo in both 
prokaryotic63, 64and eukaryotic65, 66. Living systems are not fully understood. The fact that new 
circuits are implemented in unknown environments makes difficult the realization of the desired 
behavior in extant cells67. Conversely, cell-free synthetic biology avoids the interferences derived 
from the complexity of living cells. In addition, building artificial cells that mimic cellular functions 
without the complexity of living cells could help contribute to our understanding of how living 
organisms work. However, the use of biological parts well characterized in vivo within the cell-free 
chassis is challenging. Biological parts evolved to function optimally inside of living cells, while in 
vitro conditions are undoubtedly different. Thus, the design of programmable genetically encoded 
cell-free systems is difficult because of the lack of a complete knowledge of in vivo genetics and of 
data relative to the cell-free chassis.  
Artificial cells are constructed using minimal components and are characterized by a 
compartment, made of lipids or polymers, and transcription-translation machinery to synthesize 
proteins starting from nucleic acids. Transcription and translation can be carried out using cell-free 
extracts15 such as the S30 E. coli translation system or with purified, fully defined components14. 
The system developed by Ueda, referred to as the PURE system, consists of T7 RNA polymerase 
and E. coli translation machinery. Studies have shown the suitability of both systems within 
liposomes16, 55. However, little is known regarding genetic organization influences on protein 
production in cell-free systems. Nevertheless, few recent studies attempted to define the 
influences of different ribosome binding site (RBS) in both PURE system and S30 E. coli extract48, 
transcriptional repressors47, promoters49 and gene organization inside a synthetic operon68.  
The work described in this chapter sought to define simple and practical rules to build 
genetically encoded cell-free systems. First, a set of fluorescent proteins were characterized in 
vitro with the PURE system, then a ratiometric assay was developed to quantify in a precise way 
the influences of genetic organization in synthetic operons. Finally, the method was applied in a 
series of synthetic operons that differed in sequence compositions and spacing between the 
genetic elements within the operons.  
 
2.1 In vitro expression of fluorescent proteins 
Seventeen different fluorescent proteins were expressed with the PURE system at 37 °C to 
test their functionality within the cell-free systems. Four of the fluorescent proteins contained a 
substitution of the alanine at position 206 to a lysine to inhibit dimerization69. Most of the proteins 
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tested gave rise to easily detectable fluorescent signals above the background, except for CyPet 
and monomeric CyPet (mCyPet) (Fig. 1a Lentini et al. Fluorescent proteins and in vitro genetic 
organization for cell-free synthetic biology. ACS Synth Biol 2013, 2(9): 482-489). However, the two 
cyan fluorescent proteins were able to give rise to a slightly higher fluorescent signal when 
expressed at 30 °C, presumably because the lower temperature helped the proteins to fold 
properly. All kinetic experiments showed a sigmoidal shaped curve, except for Tag-RFP-T and T-
sapphire, which did not reach their maximal fluorescence within 6 h. Kinetic data were fit to a 
logistic model to determine the time needed for each fluorescent protein to reach half of its 
maximal fluorescence (tf/2). Tf/2 value includes all the steps needed to give rise to the final 
fluorescent output starting from the DNA and, therefore, this term is influenced by the time it takes 
for transcription, translation, protein folding, and maturation of the chromophore. GFP mut3b 
showed the shortest tf/2 while Tag-RFP-T the slowest, with a time of 79 min and 300 min, 
respectively. The average tf/2 values for red, yellow, green and cyan fluorescent proteins were 245, 
122, 122 and 105 min, respectively (Fig. 1c Lentini et al. Fluorescent proteins and in vitro genetic 
organization for cell-free synthetic biology. ACS Synth Biol 2013, 2(9): 482-489). As previous 
studies reported70, yellow fluorescent proteins were the brightest proteins tested, followed by 
green, cyan and red fluorescent proteins. The dimeric version of Venus was 40 % more intense 
than the monomeric Venus, while between monomeric and dimeric versions of Cerulean and YPet 
only 5 % of difference was shown. However, the error arising from the measurements of 
fluorescence signals for individual fluorescent proteins was too high to make any conclusions.  
To reduce the experimental error due to pipetting, lamp performance and DNA quality a 
ratiometric assay was developed based on an operon containing two different fluorescent proteins. 
To construct such a system, a red fluorescent protein was ideal due to its fluorescent spectrum 
that is well separated from the spectra of other fluorescent proteins. Thus, super folder GFP 
(sfGFP) and mCherry were cloned within a bicistronic operon. Synthetic operons contained a T7 
promoter, a ribosome binding site (RBS), sfGFP gene followed by mCherry and a T7 
transcriptional terminator. Both fluorescent proteins gave rise to a detectable fluorescent signal. 
The fluorescent ratio was calculated by dividing the fluorescent intensity of sfGFP by the 
fluorescent intensity of mCherry. The kinetic profile of the ratiometric value after an initial increase, 
stabilized at 3 h and remained constant until the end of the kinetic experiment. Then, six bicistronic 
operons were built coupling mCherry with different fluorescent proteins. The profiles obtained at 
the end of the reactions were similar to the values obtained for the single constructs. Moreover, the 
experimental errors were dramatically reduced from 60 % of the single fluorescent proteins to the 8 
% of the bicistronic operons (Fig. 1d Lentini et al. Fluorescent proteins and in vitro genetic 
organization for cell-free synthetic biology. ACS Synth Biol 2013, 2(9): 482-489). The mVenus – 
mCherry pair was chosen for the next experiments thank to its greater stability and higher 
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fluorescent ratio intensity. mCherry was placed in the first position of the operon to better function 
as reference for fluorescent signal.  
2.2 Influence of the sequences upstream and downstream of the ribosome binding 
site 
The resulted bicistronic operon contained a T7 promoter, mCherry followed by mVenus and 
a T7 terminator was used to determine influences due to spacer length and sequence composition 
immediately upstream and downstream of the second gene RBS. First, different spacer lengths 
between the stop codon of mCherry and the RBS of mVenus were tested. Then the nucleotides at 
the   5’   of   mVenus   RBS   were   substituted   with   the   most   common   used   restriction   sites.   No  
correlation between different spacer length and variations in protein expression levels were found 
(Fig. 2 Lentini et al. Fluorescent proteins and in vitro genetic organization for cell-free synthetic 
biology. ACS Synth Biol 2013, 2(9): 482-489). However, a stronger effect is shown when sequence 
composition was modified. In particular, the presence of a NotI site upstream of the RBS reduced 
protein level by 70 % (Fig. 3 Lentini et al. Fluorescent proteins and in vitro genetic organization for 
cell-free synthetic biology. ACS Synth Biol 2013, 2(9): 482-489).  Subsequently,  the  region  at  the  3’  
of mVenus RBS was modified. To monitor influences due to spacing, the length of the sequence 
between the RBS and the start codon was tested by adding one nucleotide at time. The results 
showed a Gaussian distribution in which the optimal length resulted between 4 and 9 bp (Fig. 4 
Lentini et al. Fluorescent proteins and in vitro genetic organization for cell-free synthetic biology. 
ACS Synth Biol 2013, 2(9): 482-489). As previously described, also the sequence composition 
between the RBS and the start codon of mVenus was modified. Sequences containing different 
restriction sites were placed immediately downstream of the RBS. In addition, a C-rich sequence 
and mutations that introduce additional base pairing with the 16S rRNA were tested. A strong 
influence of sequence composition was shown, in particular NotI site reduced protein expression 
by 87 % and the C-rich sequence decreased expression of 98 %. A longer, more extensive base-
pairing region complementary to 16S rRNA did not affect protein production (Fig. 5 Lentini et al. 
Fluorescent proteins and in vitro genetic organization for cell-free synthetic biology. ACS Synth 
Biol 2013, 2(9): 482-489). 
Finally, non-AUG start codons were tested in vitro with the PURE system. In vivo, GUG and 
UUG function as start codons at a frequency of 14 % and 3 %, respectively71. Thus, the start 
codon AUG was substituted with GUG, UUG and CUG within the R027A construct. All start codons 
allowed protein production with a significantly reduced level comprised between 27 % and 12 %, 
respectively (Fig. 6 Lentini et al. Fluorescent proteins and in vitro genetic organization for cell-free 
synthetic biology. ACS Synth Biol 2013, 2(9): 482-489). 
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2.3 Conclusions 
The ratiometric assay developed to quantify the influences of the sequence between two 
proteins in an operon cannot discriminate between effects due to a lower production of the first 
gene or to a higher expression of the second gene. However, the assay could measure the 
influences of the sequence in the ratio of two encoded proteins in the same operon. The results 
obtained in this study showed that the influence of the sequence placed between two genes in a 
bicistronic operon is not uniform. The region at 5’  of  the  RBS  of  the  second  gene  affected  less  the  
protein   ratio   between   the   first   and   second   gene,   whereas   the   sequence   at   the   3’   strongly  
influenced protein production. Both spacer length and sequence composition changes downstream 
of the RBS resulted in different outputs. For example, a high G content negatively correlated with 
protein ratio while the presence of a UA rich sequence lead to higher protein ratio. The optimal 
spacer length between the RBS and the second gene is comprised between 4 and 9 nucleotides. 
Taken together the results showed some simple rules to follow during the construction of synthetic 
circuits for in vitro transcription-translation. Which restriction site to use, where to place the 
restriction site, and what sequences between the RBS and the gene of interest are amenable to 
protein expression were all determined. Nevertheless, certainly several additional factors influence 
transcription-translation in vitro. A better knowledge regarding how synthetic devices work in cell-
free systems will facilitate the construction of artificial cells. 
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The main approach in synthetic biology relies on the genetic engineered of living cells to 
control their behavior. The genetic content of extant cells is modified to acquire new functions. 
Many studies focus on the construction of complex genetic circuits inside living cells72, 73, 74, 75. 
However, the genetic engineering of natural cells suffers from some limitations. For example, living 
systems can evolve leading to alterations of the engineered pathways over time. However, it may 
not be necessary genetically modify living cells. Natural cells evolved several systems to sense 
their environment and to modify their behaviors to adapt to external and internal changes76, 77. 
Thus, extant cells naturally own the capability to sense various stimuli and to accomplish many 
tasks.  
The work described in this chapter presents an alternative method to modify the behavior of 
a living cell without using genetic engineering. Targeting the sensory pathway of extant cells, the 
genetically engineering moves away from the natural cells to artificial, laboratory-made cells. The 
artificial cells built in this study act as chemical translators sensing a molecule that E. coli does not 
sense on its own. In response, the artificial cells send a message that E. coli can naturally sense 
and respond to. In other word, the artificial cells sense an unrecognized message and translate it 
to a recognized message. E. coli sensing is expanded without genetically modify the natural cells. 
To sense a molecule that E. coli cannot naturally sense, the artificial cells were constructed using a 
phospholipid compartment, transcription-translation machinery made of purified components14, a 
genetically encoded element controlled by theophylline, a molecule that E. coli cannot sense on its 
own, and loaded with IPTG, a molecule that E. coli can naturally sense. The genetic element 
codes for a previously selected riboswitch responsive for theophylline78. Only in the presence of 
theophylline, the riboswitch allows the expression of the pore forming protein alpha-hemolysin 
(αHL). The protein goes to the membrane of the artificial cells, creates pores and IPTG is released 
to the outside (Fig. 3.1). The response of E. coli to IPTG released from the artificial cells was 
assessed in two different ways. First, the expression of GFP in E. coli carrying an IPTG responsive 
plasmid was used to detect the released IPTG. Then, the expression of the lac operon in non-
genetically modified E. coli through reverse transcription quantitative PCR (RT-qPCR) was 
monitored. 
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Fig. 3.1 Artificial cells.  
The artificial cells made of phospholipids contain cell-free transcription-translation machinery, genetically 
encoded theophylline riboswitch, and IPTG. In the absence of theophylline, the conformation of the 
riboswitch does not allow protein expression (left panel). In the presence of theophylline, the riboswitch 
changes  conformation  and  protein  expression  can  occur.  αHL  forms  pores  in  the  membrane,  and  the  IPTG  is  
released outside (right panel). 
 
3.1 The artificial cells can sense a molecule that E. coli cannot sense on its own 
 To build artificial cells that sense theophylline, a theophylline-sensing device was 
constructed. The genetic device was made of a T7 promoter, theophylline riboswitch and αHL 
gene. To facilitate the monitoring of the functionality of the artificial system, αHL was fused to 
super folder GFP (sfGFP) at the carboxyl terminus. Thus, only when theophylline is present, αHL is 
expressed and the reaction could be monitored by fluorimetry. However, when expressed in vitro, 
the theophylline-sensing device gave rise to similar fluorescent signals both in the presence and in 
the absence of theophylline. Since previous work showed the functionality of the same riboswitch 
in vitro52, the sequence of αHL-sfGFP was further investigated. Putative ribosome binding site 
(RBS) and ATG pairs were found within αHL-sfGFP gene, compatible with the expression of 
truncated αHL isoforms but in frame with the encoded region of sfGFP. After the confirmation of 
the presence of internal RBS in the αHL portion, one of the putative RBS was removed from the 
αHL coding sequence. When tested in vitro, the resulted theophylline-sensing device showed a 
clear difference in protein expression, in the presence and in the absence of theophylline (Fig. 2a-c 
Lentini R et al. Integrating artificial with natural cells to translate chemical messages that direct E. 
coli behaviour. Nat Commun 2014, 5: 4012).  
 Subsequently, the correct functionality of αHL to form active pores in vitro was tested. The 
theophylline-sensing device was expressed in vitro in the presence and in the absence of 
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theophylline. An aliquot of each reaction was mixed with rabbit red blood cells and hemolysis was 
measured. Only in the presence of theophylline was active αHL produced (Fig. 2d Lentini R et al. 
Integrating artificial with natural cells to translate chemical messages that direct E. coli behaviour. 
Nat Commun 2014, 5: 4012). 
 
3.2 Artificial cells translate a message for E. coli 
Once the theophylline-sensing device was shown to work in vitro, artificial cells containing 
all the necessary components were built. The theophylline-sensing device, transcription-translation 
machinery and IPTG were encapsulated inside liposomes. Phospholipid vesicles are known to be 
permeable to theophylline52 while IPTG cannot cross the lipid membrane (Supplementary figure 1. 
Lentini R et al. Integrating artificial with natural cells to translate chemical messages that direct E. 
coli behaviour. Nat Commun 2014, 5: 4012). Artificial cells were then purified by using dialysis and 
mixed with E. coli Bl21(DE3) pLysS cells carrying an IPTG responsive plasmid coding for sfGFP. 
IPTG induces expression of T7 RNA polymerase (T7 RNAP) and derepresses sfGFP expression in 
the plasmid. Artificial cells were incubated at 37 °C together with E. coli. Expression of sfGFP was 
monitored by flow cytometry. Theophylline alone was not able to induce a response in E. coli, 
IPTG could not cross the vesicles in the absence of αHL. When artificial cells were incubated with 
E. coli and theophylline, 69±3 % of the bacteria emitted fluorescence after 3 h, while in the same 
conditions but in the absence of theophylline, only 24±5 % of bacteria emitted fluorescence (Fig. 
3ab Lentini R et al. Integrating artificial with natural cells to translate chemical messages that direct 
E. coli behaviour. Nat Commun 2014, 5: 4012). Then, artificial cells were incubated together with 
untransformed E. coli to determine whether the artificial cells could elicit a natural response in non-
genetically modified cells. RT-qPCR was used to monitor lac operon expression. IPTG is well 
known to induce expression of lacZYA genes. E. coli was grown in LB to reduce background 
expression from the operon and then transferred to minimal medium. Artificial cells were added to 
the bacteria and incubated at 37 °C. RNA was then extracted and reverse transcribed. Bacteria 
incubated with artificial cells and theophylline showed a 20 fold higher expression of lacZYA genes 
(calculated from AC/(AC + theo) than samples incubated with artificial cells alone (Fig. 3c Lentini R 
et al. Integrating artificial with natural cells to translate chemical messages that direct E. coli 
behaviour. Nat Commun 2014, 5: 4012). The artificial cells were able to translate a message to E. 
coli and induced a response in natural cells. 
  
 35  
 
  
 36  
 
  




 38  
 
  
 39  
 
  
 40  
 
  
 41  
3.3 Artificial cells as a tool to reduce AI-2 uptake  
In the work presented in this chapter it has been shown the ability of artificial cells to control 
bacterial behavior through the release of IPTG. However, artificial cells could be built to send other 
types of molecules and be exploited as tools to defeat pathogens. For example, artificial cells could 
be constructed to sense the presence of Pseudomonas aeruginosa and release inhibitors of biofilm 
formation such as D-amino acids79 known to disperse biofilm or analogs of quorum sensing 
molecules to block virulence80, 81. Bacteria communicate through a process called quorum sensing 
(QS). The process depends on the diffusion of small molecules, called autoinducers, and control 
various behaviors, among them biofilm formation and virulence82.  Autoinducer 2 (AI-2) is an 
interspecies signaling molecule sensed by both Gram negative and positive bacteria83. Previous 
studies showed that AI-2 plays a role in biofilm formation in E. coli84. AI-2 accumulates 
extracellularly in the mid-late exponential phase and declines in the stationary phase because of 
uptake by a transporter cassette included in the lsr operon. The operon contains lsrACDBFG 
genes and is activated by AI-2 itself. Next to the lsr operon, lsrR, a repressor, and lsrK, a kinase, 
are divergently transcribed. The LsrR repressor binds an intergenic region of 250 bp in length 
adjacent to the lsr operon thereby repressing the transcription of the operon85. It has been shown 
that the presence of glucose in the media reduces the internalization of AI-286 due to a link 
between catabolite repression and AI-2 transport18. Catabolite repression influences AI-2 
accumulation through the cyclic AMP (cAMP)-cAMP receptor protein (CRP) complex. In the 
presence of glucose, low intracellular levels of cAMP-CRP are present, lsr operon is not 
transcribed and AI-2 import is not possible. Thus, the construction of artificial cells able to send 
glucose should indirectly block the AI-2 pathway in E. coli and reduce biofilm formation. 
Artificial cells were built as previously described58, except that they were loaded with 
glucose instead of IPTG. The theophylline-sensing  device  controls   the  production  of  αHL.   In   the  
presence   of   theophylline,   αHL   forms   pores   on   the   membrane   and   glucose   is   released.   The  
presence of glucose represses the expression of CRP leading to a downregulation of the lsr 
operon and absence of AI-2 internalization. The inhibition of AI-2 uptake was monitored in two 
ways. First, the higher amount of AI-2 in the media of E. coli incubated together with artificial cells 
was monitored by flow cytometry by using an AI-2 E. coli reporter strain. Then, the level of lsr 
transcript was monitored through RT-qPCR. 
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3.4 Methods 
3.4.1 Vesicle permeability to glucose  
A shrink-swell assay87 was performed to assess whether glucose was capable of crossing 
vesicle membranes. 1:2 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC): cholesterol 
vesicles with 10 mM calcein were prepared in buffer A (10 mM MgCl2, 100 mM KCl, 50 mM 
HEPES, pH 7.6) and purified by gel filtration chromatography with sepharose-4b. Purified vesicles 
were diluted two-fold with 1.0 M glucose (final concentration = 0.5 M) at 37 °C. The reaction was 
monitored by spectrofluorimetry with excitation and emission wavelengths of 495 nm and 515 nm, 
respectively.  
3.4.2 E. coli W3110 AI-2 reporter strain as receiver cells  
Mid-exponential E. coli W3110 transformed with a plasmid encoding GFPuv behind a T7 
promoter and a plasmid encoding T7 RNA polymerase (T7 RNAP) under the control of AI-2 were 
grown in LB supplemented with   100  μg  mL−1 ampicillin and 50  μg  mL−1 kanamycin to OD600 0.5. 
Cells were then harvested and resuspended in fresh LB. Finally, cells were added to the artificial 
cells at a final OD600 0.1. 
3.4.3 RT-qPCR analysis  
Vesicles were dialyzed as previously described58. Then, vesicles and E. coli were incubated 
for 6  h  at  37  °C.  Subsequently,  the  total  RNA  was  extracted  with  the  RNeasy  Mini kit (Qiagen). A 
quantity   of   500  ng   of   RNA   was   reverse   transcribed   using   RevertAid   Reverse   Transcriptase  
(Thermo Scientific). cDNA was quantified with a CFX96 Touch real-time PCR (Bio-Rad) with SYBR 
green  detection.  Each  sample  was  diluted   to  5  ng  and  measured in triplicate in a 96 wells plate 
(Bio-Rad) in a reaction mixture containing SsoAdvanced SYBR green supermix (Bio-Rad) and 
180  nM  of   each  primer   in  a  10  μl   finale   volume.  The  primers  used   to  quantify   crp, lsrB and lsrD 
expression were crp FW: 5′-AGACTCTGCTGAATCTGGCAA-3′, crp REV:   5′-
TCTGACCAATTTCCTGACGGG -3′,   lsrB FW:  5′- CACGGTGAAAGAATTTGGCCT -3′,   lsrB REV: 
5′- TCAATAATGCATCCGCGACATACA -3′,   lsrD FW:   5′- CGATGGCGTTTACAGATTTCGC -3′,  
lsrD REV:   5′- AGCCAGAAAACGAGGAGACAT -3′.   Gene   expression   was   normalized   to   the  
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3.5 Results 
3.5.1 Vesicle permeability to glucose  
In the artificial cells the release of glucose has to be controlled by pore formation upon the 
addition of theophylline. To assess phospholipid vesicle permeability to glucose, a shrink-swell 
assay87 was performed as previously described58. 1:2 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC): cholesterol vesicles were formed with 10 mM calcein diluted in buffer A 
(50mM HEPES, 10mM MgCl2, 100mM KCl, pH 7.6) and unencapsulated dye was removed 
through gel filtration. 1 M glucose in buffer A was added 1:1 to the vesicle suspension. The 
fluorescent signal was monitored by fluorimetry. Calcein is a self-quenching dye. Upon the addition 
of the solute, water leaks out from the vesicles to equilibrate the inner and the outside solutions. 
Therefore, the concentration of calcein increases and the fluorescent signal decreases. If the 
molecule enters within the vesicles to reach equilibrium, calcein would be diluted and the 
fluorescence signal would increase. No increase of signal was detected within 10 h of incubation at 
37 °C. 1:2 POPC: cholesterol vesicles are not permeable to glucose (Fig. 3.2). 
 
Fig. 3.2 Glucose does not cross 1:2 POPC: cholesterol vesicles. 
Fluorescent profile of 1:2 POPC: cholesterol vesicles contained 10 mM of calcein in the presence of glucose. 
A shrink-swell assay was performed to assess whether glucose was capable of crossing 1:2 POPC: 
cholesterol membranes. 1:2 POPC: cholesterol   vesicles   containing   10   mM   calcein   in   buffer   A   (50  mM  
HEPES,  10  mM  MgCl2,  100  mM  KCl,  pH  7.6)  were  mixed  with  1  M  of  glucose   (final  concentration  0.5  M).  
The fluorescent signal was monitored by fluorimetry (ex 495 nm, em 515 nm) at 37 °C for 10 h. The 
decrease in fluorescence was due to both dilution with the glucose solution and calcein self-quenching. The 
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3.5.2 The effects of glucose on E. coli 
 To assess whether glucose has an effect on AI-2 uptake, E. coli W3110 containing pTC6 
and pET GFPuv plasmids was used as an AI-2 reporter strain. The pTC6 plasmid contains the T7 
RNA polymerase (T7 RNAP) under the control of the intergenic region of lsr operon, while pET 
GFPuv contains GFPuv under the control of a T7 promoter. In the presence of AI-2, T7 RNAP is 
produced and drives the expression of GFPuv. When glucose is present in the media, it shuts 
down CRP expression, leading to low expression of the lsr operon. In the absence of the lsrACDB 
transport system, AI-2 produced from the reporter strain itself cannot enter the E. coli cells. 100 
mM of glucose were added to LB media of the AI-2 reporter strain, and the cells were incubated at 
37 °C. Each hour a few microliters were collected and analyzed by flow cytometry. When E. coli 
grew in LB without glucose, an increase over time of green positive cells was recorded until 
approximately 60 % were positive, whereas the percentage of green positive cells in samples 
treated with glucose remained stable at 5 % for each time point (Fig. 3.3a). In addition, RT-qPCR 
was performed to monitor the effects of glucose on E. coli. 4 mM glucose were added to E. coli 
Bl21(DE3) pLysS in LB and incubated at 37 °C. After 6 h, the cells were collected and the RNA 
was isolated and reverse transcribed. RT-qPCR was performed on crp and lsrBD genes as 
representatives of the lsr operon. As expected, samples treated with glucose showed a low 
expression of both CRP and lsr operon genes (Fig. 3.3b). 
 
Fig. 3.3 Effects of glucose on AI-2 uptake. 
Glucose effects on E. coli were assessed in two ways. a) Flow cytometry analysis of E. coli W3110 AI-2 
reporter strain grown in the presence or in the absence of 100 mM glucose in LB. Glucose represses CRP 
expression which cannot control expression of the lsr operon. AI-2 cannot enter the cells. As expected, a low 
percentage of green positive cells was shown in samples treated with glucose (blue bars), while control cells 
showed an increase over time of positive events (grey bars). b) RT-qPCR analysis of crp and lsrBD in the 
presence and in the absence of 4 mM glucose. E. coli Bl21(DE3) cells grown in the presence of glucose 
showed downregulation of crp, lsrB and lsrD (blue bars) compared to control cells (grey bars).  
 
3.5.3 Artificial cells control AI-2 uptake in E. coli through the release of glucose 
Once it was established the suitability of the two methods to monitor the effects of glucose 
on E. coli, artificial cells loaded with glucose were tested for their ability to control AI-2 uptake in E. 
 45  
coli cells through glucose release. Artificial cells were built as previously described58, except that 
IPTG was substituted with glucose. Only in the presence of theophylline, αHL is produced and 
forms pores in the lipid membrane of artificial cells. Glucose is then released to E. coli. Mid-
exponential cultures of E. coli Bl21(DE3) pLysS cells were incubated with artificial cells at 37 °C in 
the presence or in the absence of 5 mM theophylline. To obtain a global understanding on the 
effects of the system, RT-qPCR was performed. crp and two genes of lsr operon, lsrB and lsrD, 
were monitored. After 6 h the cells were collected and RT-qPCR was used to monitor crp, lsrB and 
lsrD levels. Artificial cells in the presence of 5 mM theophylline showed a downregulation of 
5.0±0.6 and 1.3±0.1 in crp and lsrD compared to samples in which theophylline was not present, 
respectively. No effect was shown in lsrB expression (Fig. 3.4ab). However, the effect reported in 
crp levels was higher than in the controls. Even cells incubated with 100 mM glucose showed a 
higher crp expression than in the presence of artificial cells. 5 mM of theophylline affected crp gene 
expression, leading to an upregulation of the gene, while mild effects were seen for lsrB and lsrD 
genes. The results obtained were difficult to interpret. Theophylline had an opposite effect than 
glucose on crp expression. Theophylline upregulated crp expression, while glucose downregulated 
the expression of crp. When used together within the system, theophylline and glucose led to no 
effect or minimal effect of artificial cells action on lsr operon. Moreover, the presence of artificial 
cells in general seemed to affect CRP, resulting in downstream regulation of the lsr operon.  
 
Fig. 3.4 Artificial cells partially failed to control crp and lsr expression through the release of glucose. 
RT-qPCR analysis performed on crp and lrs operons in the presence of artificial cells and theophylline. 
Artificial cells were incubated with E. coli Bl21(DE3) pLysS in the presence or in the absence of 5 mM 
theophylline.  Theophylline   allows  αHL  expression   and   the   release  of  glucose.  Glucose  downregulates the 
crp gene and in turn lsr operon transcription. a) In cells incubated with 5 mM of theophylline alone, crp 
expression was upregulated (yellow bar). Mild differences are shown from cells treated with artificial cells in 
the presence or in the absence of theophylline (green and red bars, respectively). b) The presence of 
theophylline with artificial cells did not affect lsrB and lsrD expression. AC = artificial cells, theo = 5 mM 
theophylline. 
 
To further investigate the action of artificial cells when loaded with glucose, AI-2 uptake was 
measured directly by using the E. coli W3110 AI-2 reporter strain. If the artificial cells are able to 
send glucose in the presence of theophylline, a lower GFPuv expression is expected due to the 
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absence of AI-2 uptake from the E. coli reporter strain. Artificial cells were built as previously 
described58 and incubated at 37 ºC with the E. coli W3110 AI-2 reporter strain. Each hour few 
microliters were collected and GFPuv expression was monitored by flow cytometry. Bacteria 
incubated with 100 mM of glucose showed a lower GFPuv expression compared to bacteria grown 
in LB not supplemented with 100 mM glucose (Fig. 3.5). Glucose does not cross phospholipid 
vesicles. After 3 h no clear difference was observed when artificial cells and bacteria were 
incubated in the presence or in the absence of 5 mM theophylline, with a percentage of 15 % and 
26 %, respectively. However, a higher percentage of cells (60 %) expressed GFPuv when 
incubated with theophylline alone.  
 
Fig. 3.5 No clear effects of artificial cells loaded with glucose on E. coli. 
Flow cytometry analysis of artificial cells loaded with glucose. Artificial cells were incubated with E. coli 
W3110 AI-2 reporter strain at 37 ºC in the presence or in the absence of theophylline. After 3 h cells were 
collected and analyzed by flow cytometry. If glucose is released from the artificial cells, a decrease in AI-2 
uptake, and thus a decrease in green positive cells would be expected. No clear difference was observed in 
the presence or in the absence of theophylline, 15 % and 26 % of green positive cells were recorded, 
respectively (green and red bars). Control cells grown in LB supplemented with 100 mM glucose showed a 
low percentage of green positive events (blue bar), while control cells grown in LB showed 40 % of green 
cells (grey bar). Vesicles loaded with glucose showed a lower percentage of green positive cells compared 
to control cells (black bar), probably due to vesicle breakage. Unexpectedly, cells grown in LB supplemented 
with 5 mM theophylline showed 60 % of positive events (yellow bar), a percentage higher than control cells. 
AC = artificial cells, theo = 5 mM theophylline. 
 
To further investigate the effect shown by theophylline on AI-2 uptake, the E. coli AI-2 
reporter strain was incubated with different amounts of theophylline. When 5 mM of theophylline 
were present in the media, an increment of GFPuv positive cells was detected. Samples treated 
with lower amounts of theophylline did not show any differences when compared to control cells 
grown in LB media (Fig. 3.6). Theophylline has been proposed to act as a cAMP 
phosphodiesterase inhibitor raising intracellular levels of cAMP88, thus it could have an effect on 
genes related to the cAMP-CRP pathway. Moreover, the high concentration of theophylline used 
could increase these effects. 
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Fig. 3.6 Theophylline effects on AI-2 uptake. 
Flow cytometry analysis of E. coli W3110 AI-2 reporter strain in the presence of various theophylline 
concentrations. E. coli cells were grown at 37 ºC in LB supplemented with 5 mM, 1 mM and 0.5 mM of 
theophylline. Cells grown in LB and in LB supplemented with 100 mM glucose were used as controls. After 3 
h cells grown in LB supplemented with 5 mM of theophylline showed a percentage of 60 % green positive 
cells (yellow bar), higher than control cells (grey bar). Cells treated with lower amounts of theophylline 
showed similar percentages of positive cells compared control.  
 
Experiments were then set up using 1 mM theophylline, a concentration that seemed to 
have not affect lsr operon expression. E. coli W3110 AI-2 reporter strain was incubated with 
artificial cells at 37 °C. When a lower amount of theophylline was added, the unwanted effect on 
AI-2 uptake was reduced (Fig. 3.7). However, no differences were observed in samples incubated 
with artificial cells in the presence or in the absence of theophylline. Moreover, both samples 
showed a low percentage of positive cells compared to control cells with glucose. The amount of 
theophylline could have been too low to activate the artificial cells. Glucose release over time could 
be due to leaky expression of the theophylline riboswitch, leading to the presence of the same 
glucose concentration in both samples.  
 
Fig. 3.7 Artificial cells failed to control AI-2 uptake through glucose release. 
Flow cytometry analysis of artificial cells in the presence of 1 mM theophylline. Artificial cells were incubated 
with E. coli W3110 AI-2 reporter strain at 37 ºC in the presence or in the absence of 1 mM theophylline and 
analyzed by flow cytometry. No difference was observed in the presence or in the absence of 1 mM 
theophylline, 12 % and 16 % of green positive cells were recorded, respectively (green and red bars). 
Control cells grown in LB supplemented with 100 mM glucose showed a low percentage of green positive 
events (blue bar). 1 mM of theophylline did not affect AI-2 uptake showing a similar percentage of green cells 
compared to control cells (yellow and blue bars, respectively). Glucose did not cross phospholipid 
membrane, resulting in a similar percentage of positive events compared to the control (black bar). AC = 
artificial cells. 
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3.6 Conclusions 
The results obtained showed the possibility to control natural cell behavior without direct 
genetic manipulation of the living cells. The genetic engineered components were moved from the 
living cells to more controllable artificial cells. Contrary to natural cells, the artificial cells were 
made with just known components, and the artificial cells could not grow or evolve. Once the 
artificial cells accomplish their tasks, the artificial systems degrade and the living cells go back to 
normality, thereby avoiding unwanted long-term consequences. However, this first generation of 
artificial cells suffers from several limitations, such as low encapsulation efficiency, which results in 
a population of artificial cells with different degrees of activity. In addition, the synthesis of active 
molecules starting from precursors should be integrated in the artificial system to avoid the release 
of active molecules from compartment degradation.  
Moreover, the work presented in this chapter showed the construction of a one-way 
communication path between artificial and natural cells. The artificial cells sense a molecule that E. 
coli cannot sense on its own and release a molecule that E. coli can sense. The proof-of-concept 
developed in this study could be exploited to control other pathways within natural cells. 
Unfortunately, attempts to affect E. coli QS through glucose release presented difficulties due to 
the combination of theophylline and glucose, which showed opposite effects on CRP. Thus, the 
effect of the artificial cells on the targeted lsr operon resulted in unclear data.  
However, artificial cells could be constructed to better imitate natural cellular life. 
Engineered communication between living cells have be established to coordinate bacterial 
populations89, 90 and artificial QS pathways were constructed within natural cells91, 92. It could be 
possible to construct similar pathways within artificial cells to reach a two-way communication 
between artificial and natural systems. The artificial cells could sense the living cells through QS 
and then send in return QS messages. The construction of such a system would represent a more 
complete integration between artificial and living cells. Moreover, acting on QS pathway, artificial 
cells could potentially be exploited as tools to reduce biofilm formation and defeat infections.  
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Chapter 4.  
Integrating artificial with natural cells through quorum 
sensing 
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4.1 Quorum sensing  
Bacteria are not just autonomous unicellular organisms. Instead, bacteria participate in cell-
to-cell communication processes referred to as quorum sensing (QS), a term first introduced by 
Fuqua in 1994.93 QS is a mechanism used by bacteria to coordinate gene expression in such a 
way that specific genes are either up or downregulated when a high cell density is reached. The 
process depends on small diffusible molecules, called autoinducers, that are released by bacteria 
into the external environment. As the bacterial density increases, the concentration of autoinducers 
rises until a critical threshold is reached. The internalization of the small molecules is either 
through passive diffusion or via the action of specific membrane transporters and ultimately 
regulates several physiological processes, including biofilm formation94, bioluminescence95 and 
virulence96. 
A large variety of bacteria species are known to communicate and coordinate their behavior 
through this language. One of most studied QS pathways is of is Vibrio fischeri. In the 1970s it was 
noticed that V. fischeri produces bioluminescence only at high cell density97, and depended on the 
production of a small molecules referred to as N-3-(oxohexanoyl)homoserine lactone (3OC6 
HSL)98. At low cell density, 3OC6 HSL diffuses out of the cells into the external environment, and 
when the concentration increases the quorum molecule diffuses into the cells99. 3OC6 HSL is 
recognized by a cytoplasmic receptor LuxR. The 3OC6 HSL-LuxR complex then binds a specific 
region of the DNA, thus activating the expression of the lux operon and leading to luminescence. 
The genes involved in the process are composed of two divergent transcriptional units, one 
contains the luxR gene and the other is constituted by the lux operon, luxICDABE. Between the 
two units is a 150 bp region100 that includes a specific sequence recognized by the LuxR-3OC6 
HSL complex, referred to as the lux box101. The luxI gene codes for a synthase which drives the 
synthesis of 3OC6 HSL, while luxCDABE are genes dedicated to light production102. LuxI and 
LuxR regulate bioluminescence in correlation to cell density103. At low density, LuxI is expressed at 
a basal level and produces 3OC6 HSL which is released to the outside. When the cell density is 
high, the molecule diffuses into the cells, binds LuxR, and activates light production and LuxI 
expression in a positive feedback loop99. 
The LuxI-LuxR signal response mechanism is exploited by a large number of Gram-
negative species to control a variety of density related functions. Many homologous of LuxI 
synthase and the LuxR receptor were found, such as CepI-R in Burkholderia cepacia104 or PpuI-R 
in Pseudomonas putida105. Furthermore some species are characterized by more than one LuxI-
LuxR system that act together to control different behaviors. For example, Pseudomonas 
aeruginosa contains both LasI-LasR106 and RhlI-RhlR107 QS systems that are controlled by N-(3-
oxododecanoyl)-l- homoserine lactone (3OC12 HSL) and N-butanoyl-l-homoserine (C4 HSL), 
respectively.  
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The autoinducer molecules that characterize the LuxI-LuxR systems are homoserine 
lactones (ΑHLs). The structure of ΑHL (Table 4.1) comprises a homoserine lactone ring and an 
acyl chain (from 4 to 18 carbons)108. Each QS pair is characterized by a different autoinducer 
molecule which shares a common moiety and differs from the length of the acyl chain and the 
possible substitution of a carbonyl in the third carbon109. Each ΑHL is species-specific and is 
synthesized by a specific synthase and can be recognized by a specific receptor.  
 




















lasI-lasR P. aeruginosa 
AI-2 
 
                       
 
luxS E. coli  
V. harveyi 
 
Table 4.1 AHLs and autoinducers used in this study. 
C4 HSL and 3OC12 HSL were from P. aeruginosa. 3OC6 HSL and C8 HSL were from V. fischeri. Different 
AI-2 structures from E. coli and V. harveyi are shown. 
 
Bacteria are characterized also by an interspecies QS molecule called autoinducer 2 (AI-2). 
First described in Vibrio harveyi110, AI-2 is produced by LuxS in both Gram-negative and Gram-
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positive bacteria111 (Table 4.1). LuxS homologous have been found in more than 60 different 
species112. Different roles have been proposed for AI-2, including as an additional layer of control 
for biofilm formation in E. coli84 and virulence genes in Vibrio cholerae96. 
4.2 Construction of an in vitro quorum sensing mechanism 
To integrate artificial with natural cells, the artificial cells need to sense the living cells. 
Living cells are able to sense their environment and to modify their behavior to adapt to external 
changes. Many external stimuli are recognized by bacterial cells, such pH113, temperature114 and 
stress115, leading to the regulation of thousands of genes77. Moreover bacteria release various 
small molecules such as metabolic end products116, iron chelators117 and autoinducers. Through 
these small molecules, living cells can determine optimal survive strategies and monitor their own 
population density118.  Thus, bacterial QS can be exploited in an artificial system to sense the 
presence of living cells and to communicate with them. 
To construct a synthetic QS pathway, artificial cells able to recognize the QS molecules that 
are synthesized and secreted by bacteria are needed. Therefore, the E. coli AI-2 sensory pathway 
was reconstructed in vitro. E. coli produces AI-2 through the activity of the LuxS enzyme. AI-2 
accumulates extracellular in the mid-late exponential phase and declines in the stationary phase 
as a consequence of uptake by a transporter cassette included in the lsr operon119. The operon 
contains lsrACDBFG genes and is activated by AI-2 itself120. lsrACDB genes code for the AI-2 
transport system, while lsrFG genes are involved in AI-2 degradation121. Next to the lsr operon, 
lsrR, a repressor, and lsrK, a kinase, are divergently transcribed. The LsrR repressor binds an 
intergenic region of 250 bp in length adjacent to the lsr operon thereby repressing the transcription 
of the operon85. After internalization, AI-2 is phosphorylated by LsrK. LsrR complexed with 
phosphorylated AI-2 leads to the derepression of the lsr operon.   
To mimic the AI-2 sensory pathway in vitro, a genetically encoded device in which a T7 
promoter drives the expression of lsrR, lsrK and T3 RNA polymerase (T3 RNAP) was built to 
constitutively express the three genes with cell-free transcription-translation machinery containing 
T7 RNA polymerase (T7 RNAP). A second synthetic construct expresses αHL under a T3 
promoter placed behind the intergenic region of lsr operon controlled by LsrR. A promoter cascade 
was introduced to avoid basal expression of αHL. Thus, in the absence of AI-2, LsrR represses 
αHL expression. When AI-2 is added, AI-2 is phosphorylated by LsrK, and phosphorylated AI-2 
disrupts LsrR binding, thereby allowing αHL transcription with T3 RNAP. 
To complete the construction of in vitro QS able to communicate with E. coli a synthetic 
device that synthesizes AI-2 was built to send a message to the bacteria. E. coli produces AI-2 
starting from S-adenosylmethionine (SAM), a central metabolite used as a methyl donor 
dependent on methyltransferases during the biosynthesis of nucleic acids and proteins. The 
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reaction produces a toxic intermediate, S-adenosylhomocysteine (SAH), which is rapidly 
hydrolyzed to S-ribosylhomocysteine (SRH) and adenine by Pfs, a nucleosidase. Subsequently, 
SRH is cleaved by LuxS into homocysteine and 4,5- dihydroxy- 2,3- pentanedione (DPD)122. DPD 
spontaneously cyclizes, giving AI-2. Different arrangements are possible leading to various AI-2 
molecules that can be recognized by different bacteria123. For example, AI-2 in V. harveyi is a 
cyclic borate diester110. It has been shown that AI-2 can be enzymatically produced starting from 
SAH with purified LuxS and Pfs,122, 124 and AI-2 production can be further optimized using LuxS 
and Pfs in a fusion protein, His-LuxS-Pfs-Tyr (HLPT)125. Thus, a genetically encoded HLPT to 
synthesize in vitro AI-2 was constructed. 
Other than E. coli QS, also several LuxI-LuxR QS pairs can be reconstituted in vitro. To 
mimic V. fischeri a synthetic device that comprises the luxR gene under a tet promoter was used. 
When 3OC6 HSL is present, the quorum molecule is recognized by LuxR and activates the 
transcription of the luxI gene under the correspondent responsive promoter, promoting 3OC6 HSL 
production. In the same manner the two P. aeruginosa QS systems, LasI-LasR and RhlI-RhlR 
controlled by 3OC12 HSL and C4 HSL, respectively, were constructed.  
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4.3 Methods 
4.3.1 Bacterial strains and growth conditions 
E. coli and P. aeruginosa were grown in LB. V. fischeri was grown either in LBS (tryptone 
10 g/L, yeast extract 5 g/L, NaCl 20 g/L) or photobacterium broth (ammonium chloride 0.3 g/L, 
calcium carbonate 1 g/L, casein enzymic hydrolisate 5 g/L, ferric chloride 0.01 g/L, magnesium 
sulfate 0.3 g/L, monopotassium dihydrogen phosphate 3 g/L, sodium chloride 30 g/L, sodium 
glycerophosphate 23.5 g/L, yeast extract 2.5 g/L). V. harveyi was grown in marine broth 
supplemented with 2 % of casamino acids or autoinducer bioassay (AB) medium (NaCl 17.5 g/L, 
MgSO4 12.3 g/L, casamino acids 2 g/L, 1M potassium phosphate, 0.1 M arginine and 1% glycerol 
v/v, pH 7.5) . When necessary, media were supplemented with the correct antibiotic (100 µg/mL 
ampicillin, 50 µg/mL kanamycin, or 34 µg/mL chloramphenicol). 
4.3.2 Genetic constructs 
Plasmids used in this study are listed in the appendix. To build E. coli synthetic QS 
pathway, lsrR, lsrK and lrs operon intergenic region were amplified from the E. coli MG1655 
genome  by  PCR.   αHL   and  SP6  RNA  polymerase  were   synthesized   by  Genscript,   and  T3 RNA 
polymerase was from the registry of standard biological parts. For E. coli,  ΑHL  sensor  strains  were  
generated with K575024, K575037 and T9002, which were taken from the registry of standard 
biological parts. To build LuxI-LuxR type QS, genes were taken from the registry of standard 
biological parts, while pLasRL was extracted from the P. aeruginosa PA14 genome by PCR. 
4.3.3 In vitro cell-free transcription-traslation reactions 
Synthetic E. coli QS sensor device reactions were expressed using the PURE system (New 
England BioLabs) transcription-translation cell-free machinery. Each reaction comprises 10 µL 
solution A, 7.5 µL solution B, 20 U RNase inhibitor and 250 ng DNA, unless specifically stated 
otherwise. Different amounts of enzymatically produced AI-2 were added to activate the QS 
system. Reactions were incubated at 37 ºC and sfGFP expression was monitored with a PTI 
QuantaMaster 40 UV VIS spectrofluorometer (fluorimeter) for 6 h. 
Reconstituted P. aeruginosa and V. fischeri QS sensor systems used an E. coli cell-free 
S30 extract for circular DNA (Promega). Each reaction contains, unless stated otherwise, 20 µL 
premix, 15 µL S30 extract, 5 µL amino acids mix, 40 U of RNase inhibitor and 2 µg of DNA. From 
0.1 µM to 10 µM of 3OC12 HSL, N-octanoyl-L-Homoserine lactone (C8 HSL), 3OC6 HSL or C4 
HSL were added to activate protein expression. Reactions were monitored at 37 ºC using a 
spectrofuorometer or CFX96  Touch™  Real-Time PCR Detection System (BioRad) machine for 6 
h. 
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In vitro QS sender devices were expressed either with the PURE system or the S30 T7 
High-Yield Protein Expression System (Promega). PURE system reactions contained 10 µL 
solution A, 7.5 µL solution B, 20 U RNase inhibitor 250 ng DNA and 0.5 mM of SAH. S30 T7 high 
yield E. coli S30 cell-free extract reactions were composed by 20 µL S30 premix, 18 µL T7 S30 
extract, 40 U of RNase inhibitor and 1ug of DNA. For AI-2 production, 1 mM of SAH was added. To 
synthesize  ΑHLs,  100  µM  of  acetyl-CoA and 0.5 mM of SAM were added. Reactions were carried 
out at 37 ºC from 4 h to 6 h. 
4.3.4 AI-2 extraction from culture fluids 
E. coli cells were grown overnight from a 10% glycerol stock in LB supplemented with 0.8% 
of glucose. The day after, cells were diluted 1:100 in fresh LB 0.8 % glucose and grown for 8 h at 
37 ºC at 220 RPM. Cells were removed by centrifugation at 5000 RPM for 10 min, and the 
supernatant was filtered through 0.2 µM filters and stored at -20 ºC. 
4.3.5 Enzymatic production of AI-2  
AI-2 was enzymatically produced in vitro using 12 µM of purified HLPT and 5 mM of SAH. 
Reactions were incubated overnight at 37 ºC 220 RPM. Subsequently, reactions were chloroform 
extracted to remove proteins. The aqueous phase contained AI-2. Since the enzymatic reaction 
produces in a 1:1 ratio AI-2 and homocysteine, AI-2 was indirectly quantified using 2,2'-dinitro-5,5'-
ditiodibenzoico (DTNB) reagent. The solution for quantification contained 10 µL of sample, 100 µL 
of Tris-HCl, pH 8, 50 µL working solution 2 mM DTNB 50 µM NaAc, and 840 µL of water. After 5 
min of incubation at room temperature, the absorbance at 412 nm was measured and the 
concentration of homocysteine calculated using molar extinction coefficient (13,600 M-1 cm-1) of 
the reaction product 5-thio-2-nitrobenzoic acid (TNB). 
4.3.6 V. harveyi bioluminescence assay 
To measure AI-2 production with HLPT or in vitro synthesis V. harveyi BB170 was used. 
This strain can naturally sense AI-2 but it is engineered to not sense its own autoinducer 1 (3-oxo-
N-(2-oxotetrahydrofuran-3-yl)butanamide, 3OC4 HSL). The assay was performed as described by 
Vilchez et al.126. Briefly, V. harveyi was grown overnight from 200 µL glycerol stock in AB medium 
supplemented with kanamycin, at 30 °C 220 RPM. The day after, bacteria were diluted to OD600 
0.7 and grown for 1 h and 30 min (until OD600 1.1) in AB medium. The culture was then diluted 
1:5000 and 90 µL were loaded into 96 well white plate for luminescence assay. 10 µL of sample 
was added to the wells. AB medium was used as blank, and 50 µM of enzymatically produced AI-2 
was used as a positive control. Plates were incubated at 30 °C and luminescence was monitored 
with Infinite200 PRO plate reader (Tecan) every hour. 
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4.3.7 LsrK phosphorylation activity test  
Expression of LsrK was carried out in PURE system reaction containing 10 µL solution A, 
7.5 µL solution B, 20 U RNase inhibitor and 250 ng DNA. Reaction was supplemented with 60 µM 
of ATP, 0.2 uCi of [γ-32P]ATP and 0.8 mM of AI 2 and incubated at 37 °C for 6 h. Hydrolyzed ATP 
(incubated at 100 ºC in 2 M NaOH) was added as a control. Reactions were then chloroform 
extracted to remove proteins and 2 µL aliquots were loaded on silica TLC plates, dried, and 
developed with 4:2:2 butanol: water: acetic acid. Plates were visualized with a phosphorimaging 
screen at Typhoon phosphoimager (Amersham Biosciences). 
4.3.8 The resistance of vesicles to bacteria 
To test whether bacteria could break phospholipid vesicles, a dye leakage assay127 was 
performed. Different vesicles compositions were formed as from thin lipid film and resuspended in 
10 mM of calcein dissolved in buffer A containing 50  mM  HEPES,  10  mM  MgCl2,  100  mM  KCl,  pH  
7.6. Vesicles were extruded through a polycarbonate membrane of 1 µm pore size and loaded into 
a sepharose 4B column. The first three yellow drops containing vesicles were loaded into a quartz 
cuvette and monitored at fluorimeter. After 15 min, 1:1 volume of bacteria at OD600 0.5 was added 
to the cuvette. Reactions were monitored for 10 h. The temperature was set accommodate 
bacterial growth. Then 0.3% of Triton X-100 was added as a control to break the vesicles. 
4.3.9 Artificial cells that sense 3OC6 HSL  
Aliquots of 1:2 (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) POPC: cholesterol 
vesicles were formed as previously described128. 100 µL aliquots were rehydrated with 50 µL of 
S30 E. coli extract reaction containing 20 µL S30 premix, 15 µL S30 extract, 5 µL amino acids 
mixture, 40 U of RNase inhibitor and 4 µg of DNA (RL082A). Vesicles were diluted 1:1 with LB, 
supplemented with 1 mg/mL proteinase K and 3 mg/mL RNase A. Reactions were incubated at 30 
°C for 5 h. For external 3OC6 HSL sensing, 10 µM of synthetic 3OC6 HSL was added to the 
artificial cells. For V. fischeri sensing, bacteria were first grown overnight from 200 µL glycerol 
stock at room temperature in LBS medium supplemented with ampicillin. The day after, bacteria 
were diluted 1:100 in fresh LBS medium supplemented with ampicillin and grown until OD600 1.2. 
1.8 mL of culture were loaded into 2 mL dialysis tubes, while artificial cells were added onto the 
dialysis cap. 1.8 mL of LBS were used as negative control instead of V. fischeri culture. Tubes 
were incubated at 30 °C for 5 h, then artificial cells were collected and loaded into 96 well white 
plates. 0.3 % of Triton X-100 was added to break vesicles and 100 µL of luciferase assay reagent 
(Promega) were added to the samples. After less than 5 min, the luminescence was monitored 
with a plate reader. 
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4.3.10 Artificial sender cells  
Frozen aliquots of 1:2 POPC: cholesterol vesicles were hydrated with 50 µL of 30 T7 High-
Yield Protein Expression System supplemented with 4 µg of DNA encoding the correspondent 
synthase under a T7 promoter (MC001A, MC002A, MC003A, JF005A). For the production of 
ΑHLs,  1 mM of SAM and 300 µM of acetyl-CoA were added, whereas for AI-2 production 1 mM of 
SAH was added. Artificial cells were diluted 1:3 in buffer A and 1 mg/mL proteinase K were added 
externally. Reactions were incubated at 37 °C for 6 h. In the meantime, the correspondent E. coli 
reporter strain was grown from one colony in LB supplemented with the correct antibiotic until 
OD600 0.5. Cells were harvested, resuspended in fresh LB and added to artificial cells to a final OD 
of 0.1. Samples were incubated at 37 °C, each hour few µL were collected, diluted in PBS and 
monitored by flow cytometry with a FACS canto A (BD biosciences). 
4.3.11 Artificial cells that sense and send chemical signals (V. fischeri – E. coli, V. harveyi) 
E. coli reporter strains correspondent to QS molecule were grown from one colony in LB 
supplemented with the correct antibiotic until OD600 0.5. Cells were then harvested and 
resuspended in fresh LB. Frozen aliquots of 1:2 POPC cholesterol vesicles were hydrated with 50 
µL S30 E. coli extract for circular template supplemented with 4 µg of DNA encoding 3OC6 HSL 
sensing device and the correspondent synthase (JF008A, RL079A or RL080A).  For the production 
of  ΑHLs,  1  mM  of  SAM  and  700  µM  of  acetyl-CoA were added, whereas for AI-2 production 1 mM 
of SAH was added. In the synthetic 3OC6 HSL sensing, 1 µM of 3OC6 HSL was added to 50 µL of 
artificial cells mixed with 50 µL of the correspondent E. coli reporter strain, final OD 0.1. 1 mg/mL 
of proteinase K were added. Samples were incubated at 37 °C, aliquots collected after each hour, 
diluted in PBS, and monitored by flow cytometry. For V. fischeri sensing, bacteria were grown at 28 
°C in LBS medium supplemented with ampicillin until OD600 1.2. 1.8 mL of culture were loaded into 
2 mL dialysis tubes, while 50 µL of LB were added onto the dialysis cap. Samples were incubated 
at room temperature for 2 h to equilibrate the 3OC6 HSL concentration between the two sides of 
the dialysis apparatus. Then, 50 µL of artificial cells and 50 µL of E coli reporter strain were added 
onto the dialysis cap. Samples were incubated at 37 °C. Aliquots were collected each hour, diluted 
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4.4 Results  
4.4.1 Synthetic AI-2 sensory pathway 
The first AI-2 sensory pathway mimic was constructed in vitro to respond to AI-2 produced 
by E. coli. As a proof-of-concept, the synthetic system was developed to sense AI-2,  control  αHL  
expression upon the presence of the QS molecule AI-2 and release IPTG as message to E. coli. 
To reconstitute in vitro the AI2 sensory pathway of E. coli inside of artificial cells a genetically 
encoded device, RL028K, was built. A T7 promoter drives the expression of the lsrR repressor and 
the kinase lsrK. A second synthetic  device,  named  RL023K,  in  which  αHL  expression  is  regulated  
by the intergenic region of E. coli lsr operon was built. The intergenic region comprised two 
divergent promoters: pLsrR and pLsrA. Both promoters contain a specific binding site for LsrR85. In 
the absence of AI-2,  LsrR  forms  a  tetramer,  binds  the  intergenic  region  and  represses  αHL  gene  
expression. To avoid unspecific  expression  of  αHL  before   the  binding  of  LsrR   to   its  operators,  a  
promoter cascade was inserted. Thus, the SP6 RNA polymerase (SP6 RNAP) gene is transcribed 
by T7 RNAP along with lsrR and lsrK in a polycistronic operon, and a SP6 promoter is placed 
behind the intergenic region of the lsr operon. When AI-2 is added, it is phosphorylated by LsrK 
and   disrupts   the   LsrR   tetramer,   allowing   αHL   expression   from   the   SP6   promoter.   To   test   the  
synthetic   sensory   device,   αHL  was   tagged  at   the  C-terminus with super folder GFP (sfGFP), to 
monitor gene expression through fluorescence. 
To  check  whether  SP6  RNAP  functionally  drives  αHL  expression  under  a  SP6  promoter  a  
control reaction was performed with the PURE system. The RL029A plasmid containing SP6 
RNAP was constitutively expressed from a T7 promoter, which was observed to promote the 




















Fig. 4.1 The T7-SP6 promoter cascade. 
The T7-SP6 promoter cascade was expressed in vitro with the PURE system at 37 °C. Kinetic experiments 
were monitored by fluorescence for 6 h (ex 485 nm, em 510 nm). T7 RNAP drives the expression of SP6 
RNAP, which in turn allows for the translation of sfGFP (green circles). To show that SP6 RNAP is 
necessary to express sfGFP in this cascade, a control reaction without SP6 RNAP was performed. No signal 
is shown when SP6 RNAP is not added to into the cell-free reaction (black circles). A cartoon above the 
graph gives a schematic representation of the used genetic circuit. Data shown are from constructs RL029A 
and RL042K. 
 
To test the in vitro system in the presence of LsrR, the lsr operon intergenic region was 
placed  between  the  SP6  promoter  and  sfGFP  tagged  αHL  (RL023K)  and  expressed  in  a  cell-free 
reaction together with LsrR (RL028K). In the presence of LsrR, the repressor functionally bound 
the  intergenic  region  and  repressed  αHL  expression  (Fig. 4.2).  
 
Fig. 4.2 LsrR functionally repressed gene expression in vitro. 
LsrR was expressed in vitro with the PURE system at 37 °C. Reaction was monitored for 6 h (ex 485 nm, em 
510 nm). The repressor binds the lsr intergenic  region  placed  between  SP6  promoter  and  sfGFP  tagged  αHL  
and shuts down gene expression (red circles). A cartoon above the graph gives a schematic representation 
of the used genetic circuit. lsr indicates the intergenic region of the lsr operon. Data shown are from 
constructs RL028K and RL023K. 
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Since the promoter cascade was functional and LsrR was able to repress gene expression, 
the next step was to add AI-2 to the in vitro reaction to release LsrR repression and induce gene 
expression. E. coli produces and secretes AI-2 in the mid exponential phase and the signaling 
molecule is degraded during the stationary phase. Therefore, it is possible to collect AI-2 in cell-
free culture fluids from E. coli. To monitor the presence of AI-2 in culture fluids, the V. harveyi 
reporter strain BB170 was used. The strain has the quorum sensing phenotype sensor 1- and 2+, 
meaning that it can sense AI-2 but not AI-1 and in response emit light. After 8 h of growth in LB, 
10% of the culture fluids from different E. coli strains were added to V. harveyi cultures.  E. coli 
JM109 elicited luminescence in the reporter strain, while E. coli DH5 alpha was not able to 




Fig. 4.3 AI-2 extraction from E. coli culture. 
DH5α  and   JM109  E. coli cells were grown at 37 °C until mid-exponential phase. Free culture fluids were 
filtered and mixed together with V. harveyi BB170 reporter strain. After 4 h, the AI-2 present in JM109 free 
culture fluid elicited V. harveyi luminescent  response  (light  blue  bar).  No  signal  is  shown  from  DH5α  culture  
fluid due to absence of AI-2 (black bar). AB medium was used as blank, AI-2 activity is calculated dividing 
luminescence outputs by the signal produced for the blank sample.   
 
AI-2 extracted from E. coli JM109 culture fluid was added to the in vitro reaction containing 
the reconstituted AI-2 sensory pathway. AI-2 should be phosphorylated by LsrK and phospho AI-2 
should bind LsrR, disrupting the tetramer. SP6 RNAP should then allow for the transcription of 
sfGFP   tagged   αHL.   The   kinetic   experiment   was   carried   out   at   37   °C   and   fluorescence   was  
monitored for 6 h. The synthetic AI-2 pathway did not respond to the presence of AI-2, i.e. no gene 
expression was observed upon the addition of AI-2 (Fig. 4.4).  
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Fig. 4.4 AI-2 collected from cell-free culture fluids did not derepress the synthetic AI-2 sensory pathway. 
A synthetic AI-2 sensory pathway was expressed with the PURE system at 37 °C. Kinetic experiments were 
monitored by fluorescence for 6 h (ex 485 nm, em 510 nm). The T7-SP6 promoter cascade functionally 
produced  sfGFP  tagged  αHL  (green  circles).  When  LsrR  was present, gene expression was repressed (red 
circles). However, when AI-2 produced by E. coli JM109 cells was added to the synthetic AI-2 sensory 
pathway, no derepression occurred (blue circles). Cartoons above the graph give a schematic representation 
of the used genetic circuits. lsr indicates the intergenic region of the lsr operon. Repression and derepression 
data shown are from constructs RL028K and RL023K, while cascade data are from RL029A and RL042K. 
 
Since is not possible to directly quantify AI-2 concentration in the medium, the amount of 
AI-2 added to the in vitro reaction could have been too low to derepress gene expression in our 
synthetic circuit. AI-2 could be also enzymatically synthesized through His-LuxS-Pfs-Tyr (HLPT), a 
fusion protein made of LuxS and Pfs enzymes, starting from S-adenosylhomocysteine (SAH) 
precursor. Thus HLPT was overexpressed in E. coli Bl21 cells and purified. Then the protein was 
added to its substrate SAH and incubated at 37 °C. AI-2 concentration was indirectly quantified 
using 2,2'-dinitro-5,5'-ditiodibenzoico (DTNB), which measures the free thiols group of 
homocysteine, the side product of the Pfs enzyme, produced in a 1:1 ratio homocysteine: AI-2. 
After 8 h at 37 ºC about 2 mM of AI-2 was produced (Fig. 4.5).  
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Fig. 4.5 Enzymatic production of AI-2. 
Purified HLPT synthesized AI-2 starting from the precursor SAH after overnight incubation at 37 °C. a) A 
scheme of AI-2 synthesis through HLPT. SAH is hydrolyzed to SRH and adenine by Pfs. Subsequently, SRH 
is cleaved by LuxS into homocysteine and DPD in a 1:1 molar ratio. DPD spontaneously cyclizes, giving AI-
2. b) AI-2 was indirectly quantified with DTNB, measuring the free thiol groups of homocysteine. Values were 
calculated with the extinction coefficient of TNB2- at 412 nm (13,600 M-1 cm-1). 
 
Enzymatically produced AI-2 was then added at various concentrations to the in vitro 
reaction expressing the synthetic AI-2 sensory pathway. Kinetic experiments were monitored with 
a plate reader for 6 h. In all of the conditions, no sfGFP expression was observed upon the 
addition of synthetic AI-2 (Fig. 4.6).  
 63  
 
Fig. 4.6 Enzymatically produced AI-2 did not derepress the synthetic AI-2 sensory pathway. 
The synthetic AI-2 sensory pathway was expressed with the PURE system at 37 °C. Kinetic experiments 
were monitored by fluorescence for 6 h (ex 485 nm, em 510 nm). 40 µM (blue circles) and 260 µM (light blue 
circles) were added at the beginning of the reactions. No derepression occurred in the presence of AI-2. A 
cartoon above the graph gives a schematic representation of the used genetic circuit. lsr indicates the 
intergenic region of the lsr operon. Data shown are from constructs RL028K and RL023K. 
 
 
Neither cell-free culture fluids nor enzymatically produced AI-2 were able to restore gene 
expression. Taking in account that the synthetic AI-2 sensory pathway is made of different 
modules, each component was further investigated to ensure the functionality of each single part. 
LsrK is a kinase that should be constitutively expressed by T7 RNAP present in the cell-free 
transcription-translation reaction. LsrK should recognize and phosphorylate AI-2. Only phospho AI-
2 can bind LsrR and disrupt the tetramer. To investigate LsrK functionality, the construct containing 
the LsrR, LsrK and SP6 RNAP was expressed with the PURE system for 6 h at 37 ºC. AI-2 was 
then added to the reaction and incubated for 1 h at 37 ºC. The reaction was then placed together 
with V. harveyi BB170 reporter. The reporter strain can sense AI-2 but not phospho AI-2 since 
phosphorylated AI-2 cannot cross the bacterial membrane. Enzymatically produced AI-2 and cell-
free culture fluids from E. coli JM109 were used as positive controls, culture fluid from E. coli DH5α  
was used as a negative control. No AI-2 activity was observed when AI-2 was incubated with LsrK, 
meaning that the vast majority of the AI-2 was converted to phospho AI-2 by the kinase LsrK (Fig. 
4.7). 
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Fig. 4.7 LsrK phosphorylated AI-2 into phospho AI-2. 
LsrK was expressed in vitro with the PURE system at 37 °C. a) A schematic representation of the 
experiment performed. LsrK phosphorylates AI-2 in phospho AI-2. V. harveyi can sense AI-2 and emits 
luminescence, but not phospho AI-2. b) AI-2 was added to the reaction and incubated for 1 h at 37 °C. The 
reaction was mixed together with V. harveyi BB170 reporter strain. Phospho AI-2 cannot cross V. harveyi 
membrane. No luminescence output was detected from the reporter strain (light blue bar). Enzymatically 
produced AI-2 (dark green bar) and E. coli JM109 cell-free culture fluid (green bar) were used as positive 
controls. E. coli DH5α  cell-free culture fluid was used as negative control. A cartoon above the graph gives a 
schematic representation of the construct used (RL028K).  
 
To confirm LsrK activity, thin layer chromatography (TLC) was performed. LsrK catalyzes 
the conversion of AI-2 into phospho AI-2 with the simultaneous conversion of ATP to ADP. 
Therefore, LsrK was expressed in vitro as previously described, y32P-ATP and AI-2 were added to 
the reaction and incubated for 6 h at 37 ºC. A few microliters were spotted onto a silica TLC plate 
and run in 4:2:2 butanol: water: acetic acid. After incubation with LsrK, ATP was no longer present 
in the reaction and a lower spot that did not migrate on the TLC plate appeared (Fig. 4.8). Based 
on previous studies performed by Xavier et al.121 the non-migrating spot was identified as phospho 
AI-2. Both the TLC and the V. harveyi bioluminescence assays confirmed that LsrK is working 
properly under the in vitro conditions exploited. 
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Fig. 4.8 TCL confirmed LsrK activity. 
LsrK was expressed in vitro with the PURE system at 37 °C supplemented with 0.2 uCi [γ32P]-ATP and 0.8 
mM of AI-2. Samples were run on a TLC plate with 4:2:2 butanol: water: acetic acid. The lower spot present 
in the third row corresponds to AI-2 that does not migrate under the conditions used here. [γ32P]-ATP and 
hydrolyzed ATP were added as controls. Data shown are from construct RL028K. 
 
The second component of the in vitro AI-2 sensory pathway is the repressor LsrR. Previous 
analysis showed the absence of gene expression when LsrR is present but no release of 
repression upon the addiction of AI-2. To make sure that the absence of gene expression was due 
to LsrR repression and not to depletion of resources as a consequence of transcription-translation 
of LsrR itself, LsrR was mutated to inactivate the protein. It was previously shown that Y26H and 
Q33A mutations reduce LsrR DNA binding activity129. LsrR was mutated and tested in vitro. As 
expected,  Y26H  Q33A  LsrR  was  not  able   to   repress  sfGFP   tagged  αHL  expression,  underlining  
that the absence of signal in the reconstituted system is due to the correct functionality of wild type 
(WT) LsrR (Fig. 4.9).  
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Fig. 4.9 Y26H Q33A LsrR was not able to repress gene expression. 
Y26H Q33A LsrR was expressed in vitro with  the  PURE  system  at  37  °C  together  with  sfGFP  tagged  αHL  
under the control of SP6 promoter and the lsr operon intergenic box. The LsrR variant was not able to bind 
the lsr intergenic region and repress gene expression (yellow circles). WT LsrR was added as control (red 
circles). Reactions were monitored for 6 h by fluorimetry (ex 485 nm, em 510 nm). Cartoons above the graph 
give a schematic representation of the used genetic circuit. lsr indicates the intergenic region of the lsr 
operon. LsrR variant data shown are from constructs RL064K and RL023K, WT LsrR data are from and 
CD200A and RL023K. 
 
A synthetic version of the E. coli AI-2 sensing pathway was implemented with a promoter 
cascade in order to introduce a delay in target gene expression and thus to avoid leaky 
expression. In the RL028K plasmid lsrR, lsrK and SP6 RNAP were expressed as a polycistronic 
operon. Gene position within a synthetic operon can influence the amount of protein produced by 
the system68. In particular, since the SP6 RNAP was placed in the last position, expression of SP6 
RNAP was reduced in comparison to LsrR. Moreover, the PURE system was optimized for T7 
RNAP expression, meaning that SP6 RNAP could potentially need other conditions to work in an 
efficient manner. To test SP6 RNAP efficiency, the lsr intergenic region was deleted to allow the 
expression  of  sfGFP  tagged  αHL  also  in  the  presence  of  LsrR.  The  construct,  referred  as  RL042K, 
was expressed with the PURE system together with RL028K. The data confirmed that low protein 
yield was obtained with SP6 RNAP in the synthetic system (Fig. 4.10).  
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Fig. 4.10 Low protein expression is driven from SP6 RNAP. 
SP6 RNAP placed in RL028K polycistronic operon was expressed with the PURE system at 37 °C. A 
plasmid  encoded  sfGFP  tagged  αHL  from  SP6  promoter without the lsr intergenic region was added. The T7-
SP6 promoter cascade produced a very low amount of protein when SP6 RNAP is transcribed from the 
polycistronic operon (dark green circles, RL028K). The T7-SP6 RNAP promoter cascade in which SP6 
RNAP is transcribed from a single gene construct was added as control (green circles). Reactions were 
monitored for 6 h by fluorimetry (ex 485 nm, em 510 nm). Cartoons above the graph give a schematic 
representation of the used genetic circuits. Promoter cascade data shown are from constructs RL029A and 
RL042K, Data shown as RL028K are from RL028K and RL042K. 
 
To improve expression from SP6 RNAP, a third plasmid (RL049A) containing a SP6 
promoter behind the SP6 RNAP gene was inserted to create a positive loop and increase the SP6 
RNAP concentration within the cell-free reaction. However, no difference was observed in the 
presence of the extra SP6 RNAP plasmid (Fig. 4.11).  
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Fig. 4.11 SP6 RNAP positive loop did not increase protein yield. 
RL049A containing SP6 RNAP under SP6 promoter control was expressed with the PURE system together 
with   RL028K   and   a   construct   encoded   sfGFP   tagged   αHL   from   SP6   promoter   without   the   lsr operon 
intergenic region (dark green circles, RL028K). No increment of fluorescence output was shown when 
compared to T7-SP6 RNAP promoter cascade into the polycistronic operon (green circles, + pSP6 SP6 pol). 
Reactions were monitored for 6 h by fluorimetry (ex 485 nm, em 510 nm). Cartoons above the graph give a 
schematic representation of the used genetic circuits. Data shown as RL028K are from RL028K and 
RL042K. Data shown as +pSP6 SP6 pol are from RL028K, RL042K and RL049A. 
 
Better conditions could be necessary to improve the expression resulting from SP6 RNAP. 
Therefore, cell-free reactions were optimized to help both the polymerase and the transcription-
translation machinery. Dithiothreitol (DTT) was shown to enhance RNA polymerase activity. 
Similarly, the availability of NTPs was shown to be an important determinant of the yield of RNA130. 
Upon the addition of 1 mM ATP or 1 mM fresh DTT, only a slightly increment in protein production 
was achieved in the transcription-translation reaction. While the addition of both NTPs and DTT 
completely shut down the expression (Fig. 4.12). 
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Fig. 4.12 DTT helped SP6 RNAP activity. 
T7-SP6 RNAP promoter cascade in a polycistronic operon was expressed with the PURE system at 37 °C 
(blue circles, control). 1 mM of DTT was added to the reaction to enhance SP6 RNAP activity, which showed 
a higher protein production (green circles, 1mM DTT) when compared with the standard PURE system 
reaction (blue circles). No increment in fluorescence was shown when 1 mM ATP was added (dark green 
circles, 1 mM ATP) or both DTT and NTPs were added (light blue circles, NTPs + 1 mM DTT). Reactions 
were monitored for 6 h (ex 485 nm, em 510 nm). A cartoon above the graph gives a schematic 
representation of the used genetic circuit. Data shown are from RL028K and RL042K.  
 
The negative results obtained with the T7-SP6 cascade lead to the substitution of the SP6 
RNAP with T3 RNAP to better improve the synthetic circuit. To construct a T7-T3 cascade, a 
plasmid in which a T7 promoter drives the expression of the T3 RNAP (RL053A) was built, while a 
T3 promoter was placed   in   front   of   sfGFP   tagged   αHL   (RL054K)   in   a   second   construct.   As  
previously described, a T7-T3 cascade was tested to assess its functionality in vitro. The new 
promoter cascade was functional, and T3 RNAP was more efficient than SP6 RNAP within the 
synthetic circuit (Fig. 4.13).  
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Fig. 4.13 T7-T3 RNAP cascade. 
T7-T3 promoter cascade was expressed in vitro with the PURE system at 37 °C. Kinetic experiments were 
monitored by fluorimetry for 6 h (ex 485 nm, em 510 nm). T7 RNAP drives the expression of T3 RNAP, 
which in turn induces expression of sfGFP (green circles). To determine that T3 RNAP is necessary to 
express sfGFP, a control reaction without T3 RNAP was performed. No signal is shown when T3 RNAP is 
not added to into the cell-free reaction (black circles). A cartoon above the graph gives a schematic 
representation of the used genetic circuit. Data shown are from RL053A and RL054K. 
 
However, a lower unspecific expression was observed when synthesis was driven by T7 
RNAP from T3 promoter, that is, T7 RNAP weakly recognizes the promoter of T3 RNAP. Next, the 
SP6 RNAP gene in the synthetic operon was substituted with T3 RNAP (RL060K), and the new 
circuit was tested in the presence and in the absence of AI-2. A construct in which the lsr 
intergenic  region  was  absent  was  used  as  control.  LsrR  repressed  transcription  of  αHL  even   if  a  
low background expression is shown (Fig. 4.14); however, gene expression was not recovered 
upon the addition of AI-2. The substitution of the RNA polymerase within the reconstructed AI-2 
sensory pathway did not help the synthetic system in sensing the presence of the molecule.  
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Fig. 4.14 AI-2 did not derepress the synthetic AI-2 sensory pathway constructed with T3 RNAP. 
The synthetic AI-2 sensory pathway was expressed with the PURE system at 37 °C. The kinetic experiments 
were monitored by fluorimetry for 6 h (ex 485 nm, em 510 nm). The T7-T3 promoter cascade functionally 
produced  sfGFP  tagged  αHL  (green  circles).  When  LsrR  was  present,  LsrR  repressed  gene  expression  (red  
circles). However, when AI-2 was added to the synthetic AI-2 sensory pathway expressed with the PURE 
system, no derepression occurred (blue circles). Cartoons above the graph give a schematic representation 
of the used genetic circuits. lsr indicates the intergenic region of the lsr operon. Repression and derepression 
data shown are from constructs RL059K and RL060K, while cascade data are from RL054K and RL060K. 
 
 Another complication was represented by the high concentration of repressor produced 
from the synthetic circuit. It has been shown that the amount of protein can vary upon the presence 
of different start codon both in vivo131 and in a cell-free transcription-translation system61. In the 
attempt to reduce the amount of LsrR protein present in the system, the ATG start codon was 
mutated to TTG in the resulting plasmid RL061K. However, the lower amount of LsrR did not 
facilitate the release of repression (Fig. 4.15). 
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Fig. 4.15 A lower amount of LsrR did not allow derepression from AI-2. 
A synthetic AI-2 sensory pathway was expressed with the PURE system at 37 °C. Reactions were monitored 
for 6 h (ex 485 nm, em 510 nm). The ATG start codon of lsrR was replaced by a TTG. AI-2 did not release 
repression even when a lower amount of the repressor was present (dark green circles, TTG lsrR). A 
derepression reaction with LsrR expressed from an ATG start codon containing gene was performed as 
control (green circles, ATG lsrR). Cartoons above the graph give a schematic representation of the used 
genetic circuits. lsr indicates the intergenic region of the lsr operon. ATG lsrR data shown are from 
constructs RL059K and RL060K, while TTG lsrR data are from RL059K and RL061K. 
 
In E. coli, LsrR binds a 260 bp region upstream of the lsr operon. This region is composed 
of two divergent promoters, pLsrR and pLsrA. Different groups studied the minimum number of 
nucleotides necessary for LsrR binding,85 and four putative binding sites were found. Inside this 
region, four sequences were found to be recognized by the repressor in its tetrameric form, and 
each promoter contained two of these identified sequences. In order to test whether a shorter 
intergenic region could help release the repression in vitro, the entire lsr intergenic region was 
substituted with shorter parts. Two different intergenic regions were then tested, named pLsrA 
(RL063K) and pLsrR (RL065K). Only pLsrR gave expression when tested with the T7-T3 promoter 
cascade. However, LsrR was no longer able to repress gene expression (Fig. 4.16). 
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Fig. 4.16 LsrR did not bind pLsrR promoter and failed to repress gene expression. 
A synthetic AI-2 sensory pathway was expressed with the PURE system at 37 °C. Protein expression 
occurred   in   the   control   reaction   where   pLsrR   was   placed   between   pT3   and   sfGFP   tagged   αHL   (green  
circles). LsrR was not able to bind pLsrR and repress gene expression (red circles). Reactions were 
monitored for 6 h by fluorimetry (ex 485 nm, em 510 nm). Cartoons above the graph give a schematic 
representation of the used genetic circuits. plsrR indicates part of the intergenic region of the lsr operon. 
plsrR data shown are from constructs RL053A and RL065K, while pLsrR + LsrR data are from RL053A, 
RL065K and CD200K. 
 
Recently a LsrR variant was obtained through directed evolution132. Enhanced LsrR (eLsrR) 
showed in vivo a higher repression activity and also lead to higher expression in the presence of 
AI-2. Thus, LsrR was mutated into eLsrR and tested in with the in vitro AI-2 sensory pathway. As 
expected,   the   eLsrR   variant  was  able   to   bind   to   the   pLsrR   region   and   repress  αHL  expression;;  
however, expression was not restored when AI-2 was added to the reaction (Fig. 4.17). 
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Fig. 4.17 AI-2 did not derepress the synthetic AI-2 sensory pathway made with eLsrR. 
A synthetic AI-2 sensory pathway was expressed in vitro with the PURE system at 37 °C. Reactions were 
monitored for 6 h by fluorimetry (ex 485 nm, em 510 nm). WT LsrR was replaced with eLsrR. eLsrR 
functionally bound the lsr intergenic region and repressed protein expression (red circles). When AI-2 was 
added, no derepression was observed (blue circles). Cartoons above the graph give a schematic 
representation of the used genetic circuits. lsr indicates the intergenic region of lsr operon. Data shown are 
from constructs RL053A. RL059K, RL068K, CD200K and CD201K. 
 
In the previous genetic system tested, the lsr intergenic region was placed in a way that 
allowed expression from a pLsrA promoter. Since no expression was shown when only pLsrA was 
used within a cell-free reaction, this region was inverted, leading to a construct which was under 
the control of pLsrR. LsrR was not able anymore to tightly bind the region and partially failed to 
repress gene expression (Fig. 4.18). 
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Fig. 4.18 Reverting lsr intergenic region did not lead to AI-2 derepression. 
A synthetic AI-2 sensory pathway was expressed in vitro with the PURE system at 37 °C. Reactions were 
monitored for 6 h by fluorimetry (ex 485 nm, em 510 nm). The lsr operon intergenic region was reverted to 
allow expression from a pLsrR promoter. The T7-T3 promoter cascade functionally produced sfGFP tagged 
αHL  (green  circles).  LsrR  partially  failed  to  repress  gene  expression  (red  circles).  However,  when  AI-2 was 
added to the synthetic AI-2 sensory pathway, no derepression occurred (blue circles). Cartoons above the 
graph give a schematic representation of the used genetic circuits. rlsr indicates the inverted intergenic 
region of the lsr operon. Repression and derepression data shown are from constructs RL060K and RL070K, 
while cascade data are from RL053K and RL070K. 
  
 
Since two binding sites for cAMP receptor protein (CRP) were previously identified within 
the lsr intergenic region,119 we explored the use of CRP in our genetic circuit. Mutations in both 
CPR binding sites were previously shown to drastically reduce expression from both pLsrR and 
plsrA. The CRP protein seems to be fundamental for the correct functionality of the AI-2 sensory 
pathway. Thus, a plasmid encoded CRP behind a T7 promoter (RL076A) was inserted into the 
synthetic circuit. 1 mM of cAMP was added and the reactions were monitored at 37 ºC for 6 h. 
Finally, upon the addition of AI-2, a slight elevation  of  αHL  expression  was  observed  (Fig. 4.19). 
Later experiments described in this chapter lead to the conclusion that the cell-free transcription-
translation machinery of the PURE system was not compatible with a functional genetic circuit that 
was responsive to AI-2. The synthetic AI-2 sensory pathway was thus tested with the S30 T7 High-
Yield Protein Expression System. 
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Fig. 4.19 CRP facilitated AI-2 induced derepression. 
The synthetic AI-2 sensory pathway was expressed in vitro with the PURE system at 37 °C. Reactions were 
monitored for 6 h (ex 485 nm, em 510 nm). CRP and cAMP were added to the cell-free reaction. When LsrR 
was present, LsrR repressed gene expression (yellow circles, control). When AI-2 was added to the 
synthetic AI-2 sensory pathway in the absence of CRP, no expression was observed (green circles, AI-2). 
CRP did not derepress gene expression when present alone (light blue, CRP). When AI-2 was added to the 
synthetic AI-2 sensory pathway in the presence of CRP, low level derepression was observed (blue circles, 
CRP + AI-2).  A cartoon above the graph gives a schematic representation of the used genetic circuit. lsr 
indicates the  intergenic region of the lsr operon. Data shown are from constructs RL059K and RL060K, 
RL076A contains CRP. 
    
 
 The presence of the CRP protein helped the synthetic AI-2 sensory pathway in responding 
to AI-2; however, the expression obtained was low. The CRP protein is known to facilitate the 
binding of E coli RNA polymerase (E. coli RNAP) to the promoter 133. Thus, another cell-free 
transcription-translation machinery containing E coli RNAP was tested. The S30 T7 High-Yield 
Protein Expression System consists of an E. coli cell-free extract containing both E. coli RNAP and 
T7 RNAP. The synthetic AI-2 sensory pathway was tested with this new cell-free system to 
investigate if the presence of E coli RNAP together with cAMP-CRP could lead to higher protein 
production in response to AI-2. However, when the QS molecule was added to the reaction, no 
protein expression was observed with the S30 T7 High-Yield Protein Expression System (Fig. 
4.20). 
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Fig. 4.20 Synthetic AI-2 sensory pathway did not work in a S30 E. coli extract. 
The synthetic AI-2 sensory pathway was expressed in vitro with the S30 T7 high yield protein expression 
system at 37 °C with cAMP-CRP. When AI-2 was added, no derepression was observed (blue circles). 
Reaction was monitored for 6 h by fluorimetry (ex 485 nm, em 510 nm). A cartoon above the graph gives a 
schematic representation of the used genetic circuit. lsr indicates the intergenic region of the lsr operon. Data 
shown are from constructs RL059K and RL060K, RL076A contains CRP. 
 
4.4.2 AI-2 artificial sender cells 
E. coli synthesizes its own QS molecule through LuxS synthase. The pathway consists of 
three enzymes. First, a methyltransferase transforms SAM (S-adenosylmethionine) into SAH (S-
adenosylhomocysteine), a toxic bioproduct which is rapidly converted to SRH (S-
ribosylhomocysteine) by the enzyme Pfs. SRH is then used as a substrate by LuxS to obtain AI-2 
and homocysteine in a 1:1 ratio. It has been shown that purified HLPT is able to produce in vitro 
AI-2 starting from the SAH precursor. To reconstitute in a cell-free system the synthesis of AI-2, 
HLPT was genetically encoded in JF006A in which a T7 promoter drives the expression of the 
fusion protein. HLPT was expressed with the PURE system for 6 h at 37 °C together with 0.5 mM 
of SAH. The reaction was then added to the V. harveyi BB170 reporter strain to monitor the 
production of AI-2. No response from the reporter strain was observed when the PURE system 
was used as the transcription-translation system (Fig. 4.21). Therefore, the HLPT plasmid was 
next expressed with the S30 T7 High-Yield Protein Expression System. After 6 h of reaction 
together with 0.5 mM of SAH, a bioluminescence signal was detected from V. harveyi, showing the 
production of AI-2 within the reaction. 
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Fig. 4.21 AI-2 was produced in vitro with the S30 T7 high yield protein expression system. 
JF006A contained HLPT under pT7 was expressed in vitro at 37°C with SAH precursor. Product reactions 
were mixed together with V. harveyi BB170 reporter strain. When expressed with the PURE system, no AI-2 
was synthesized (blue bar). AI-2 was produced with the S30 T7 high yield protein expression system (light 
blue bar). A cartoon above the graph gives a schematic representation of the used construct. 
 
AI-2 does not freely cross the membrane of E. coli, but AI-2 is internalized through a 
specific transport system encode by lsrACDB. However, previous studies showed a slow 
permeability of AI-2 to phospholipid membranes which could be enhanced by the addition of the 
pore   forming   protein   αHL56. Thus the permeability of AI-2 to phospholipid vesicles was tested. 
Purified HLPT was encapsulated inside of phospholipid vesicles made by different lipid 
compositions together with SAH precursor. After vesicles formation, reactions were left at 37 °C for 
6 h. Protease K was added to the outside of the vesicles to avoid the external production of AI-2. 
Vesicles were then added to V. harveyi BB170 reporter strain to measure the presence of AI-2 
released outside of the vesicles. Both 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) 
and 1:1 POPC: cholesterol vesicles were permeable to AI-2 produced inside of the lipid 
compartments (Fig. 4.22).  
 
Fig. 4.22 Phospholipid membranes were permeable to AI-2. 
AI-2 was enzymatically produced inside different vesicles compositions. Samples were mixed together with 
V. harveyi BB170 reporter strain and luminescence output was monitored. Both POPC and POPC: 
cholesterol vesicles were permeable to AI-2 (green and light blue bars, respectively). AI-2 was added as a 
positive control. Empty vesicles were used as a negative control. 
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Next, genetically encoded HLPT was expressed inside of phospholipid vesicles. 1:1 POPC 
cholesterol lyophilized vesicles were hydrated with S30 T7 high yield expression system containing 
DNA and SAH precursor. After 6 h of incubation at 37 ºC, the samples were mixed with V. harveyi 
BB170 reporter strain and luminescence was monitored. Artificial cells failed to elicit a response in 
the reporter strain, consistent with no AI-2 production after 6 h (Fig. 4.23).  
 
 
Fig. 4.23 No AI-2 was produced in 1:1 POPC: cholesterol vesicles. 
JF006A was encapsulated together with in S30 T7 high yield protein expression system at 37 °C. After 6 h, 
artificial cells were added to V. harveyi BB170 reporter strain and luminescence output was monitored. No 
AI-2 is produced in the artificial cells (light blue bar). Enzymatically produced AI-2 was added as positive 
control (blue bar). A cartoon above the graph gives a schematic representation of the used construct within 
vesicles. 
 
Therefore another composition was evaluated to assess whether another compartment 
could facilitate AI-2 synthesis and release. 1:2 POPC: cholesterol vesicles were hydrated with 
HLPT plasmid, S30 T7 high yield expression system and SAH precursor. Samples were left at 37 
°C for 6 h. To determine the permeability properties associated with the lower concentrations of AI-
2 produced from cell-free expression, the vesicles were either untreated or treated with the 
addition of Triton X-100,  sonication,  or  purified  αHL  that  was  added  from  the  outside  of  the  vesicles 
after 6 h incubation. Samples were then added to the reporter strain and luminescence output was 
measured. Artificial cells made of 1:2 POPC: cholesterol allowed AI-2 production and release to 
the external environment (Fig. 4.24).  
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Fig. 4.24 AI-2 is produced in 1:2 POPC: cholesterol vesicles. 
JF006A was encapsulated together with the S30 T7 high yield protein expression system at 37 °C. After 6 h, 
artificial cells were added to V. harveyi BB170 reporter strain and luminescence was monitored. 1:2 POPC: 
cholesterol artificial cells produced AI-2, which was released to the outside (light blue bar). No differences 
are shown in sample treated after 6 h incubation with sonication  (green  bar),  αHL (red bar), Triton X- 100 
(yellow bar). Enzymatically produced AI-2 was added as positive control (blue bar). A cartoon above the 
graph gives a schematic representation of the used construct within vesicles. 
 
No improvements were shown in samples treated with  αHL,  sonication  or  Triton  X-100. The 
results obtained showed that AI-2 is produced by the artificial cells and can freely cross the 
phospholipid membrane.  
 
4.4.3 In vitro reconstruction of LuxR sensory QS  
After the construction in vitro of the E. coli AI-2 QS pathway, the LuxI-LuxR QS pathway used by 
V. fischeri and P. aeruginosa were built in vitro. The LuxI-LuxR QS system is an intraspecies 
communication module exploited by a large number of Gram-negative bacteria. Various LuxI-LuxR 
homologous are   found   in   bacteria   that   are   able   to   recognize   specific   ΑHLs   molecules.   P. 
aeruginosa is characterized by two LuxI-LuxR QS systems, which act together to coordinate QS 
process. The first QS system comprises the receptor LasR and the synthase LasI. LasI 
synthesizes N-(3-oxododecanoyl)-l- homoserine lactone (3OC12 HSL), a quorum molecule that is 
recognized by LasR. When 3OC12 HSL binds its receptor, the complex stabilizes LasR, binds a 
specific DNA binding site, named the las box, and allows transcription from a specific promoter. 
The second QS system behaves in the same manner and involves RhlR and RhlI.  
In order to build in vitro a 3OC12 HSL sensing device, lasR was placed downstream of an 
E. coli promoter derived from a synthetic promoter library, named J23100. Whereas GFP mut3b 
was cloned in order to be transcribe from pLasRL promoter to monitor the functionality of the 
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system. pLasRL promoter is a 3OC12 HSL responsive promoter which drives in vivo the 
expression of the elastase gene in P. aeruginosa. The construct, RL073C, was adapted from a 
previous study by Freemont et al.49 that showed the in vitro reconstruction of a functional 3OC12 
HSL sensing system. LasR is constitutively expressed from J23100, only in the presence of 
3OC12 HSL the complex LasR-3OC12 HSL binds pLasRL and activates expression of GFP 
mut3b. The sensing device was expressed in S30 T7 high yield expression system, in the 
presence and in the absence of 3OC12 HSL. After 6 h at 37 ºC no expression was observed in the 
system when 3OC12 HSL was added (Fig. 4.25). 
 
Fig. 4.25 3OC12 HSL did not activate protein expression. 
Fluorescent intensities after 6 h of expression of RL073C in vitro with the S30 T7 high yield protein 
expression system at 37 °C. Fluorescence was monitored with ex 501 nm and em 511 nm. When 10 µM of 
3OC12 HSL no signal is shown from the reaction (green bar) compared to the negative control (black bar). A 
cartoon above the graph gives a schematic representation of the used genetic circuit. Data shown are from 
construct RL073C. 
 
The LasRL promoter comprises the complete region upstream of the elastase gene. The 
shorter version, named pLasB, is known to functionally respond to 3OC12 HSL in vivo. Thus 
pLasRL was substituted with pLasB within the genetic construct (K575024) and tested in vitro. 
Again, the shorter responsive promoter failed to drive GFP expression when 3OC12 HSL was 
present (Fig. 4.26). 
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Fig. 4.26 3OC12 HSL did not activate protein expression from pLasB responsive promoter. 
Fluorescent intensities after 6 h of expression of the 3OC12 HSL sensing part in vitro with a S30 T7 high 
yield protein expression system at 37 °C (ex 501 nm, em 511 nm). When 10 µM of 3OC12 HSL was added, 
no signal was present (green bar) compared to the negative control (black bar). A cartoon above the graph 
gives a schematic representation of the used genetic circuit. Data shown are from construct K575024. 
 
Data collected in our lab showed a low expression yield derived from J23100 promoter 
library, thus the synthetic promoter was replaced in both constructs with a tet promoter to assess 
whether the lack of protein production in the synthetic 3OC12 HSL sensing system was due to a 
low expression of LasR. RL083C contains lasR behind a tet promoter and GFP mut3b controlled 
by pLasRL. RL084C comprises lasR behind the tet promoter and GFP mut3b controlled by pLasB.   
Both genetic devices were expressed with the S30 T7 high yield expression system in the 
presence and in the absence of 3OC12 HSL. After 6 h no differences in GFP signal were recorded 
upon the addition of 3OC12 HLS (Fig. 4.27). 
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Fig. 4.27 3OC12 HSL did not activate protein expression when the tet promoter constitutively drove LasR 
expression. 
RL083C and RL084C were expressed in vitro with the S30 T7 high yield protein expression system at 37 °C. 
Kinetic experiments were monitored at CFX 96 Real-Time PCR machine for 6 h using SYBR green filter. No 
differences were observed in the presence and in the absence of 3OC12 HSL in both constructs. A cartoon 
above the graph gives a schematic representation of the used genetic circuits. 
 
Previous studies showed the ability of the 3OC12 HSL-LasR complex to recognize and bind 
in vivo to the lux box region contained in the promoter of LuxR (pLuxR), similar to that seen for V. 
fischeri LuxI-LuxR QS134. Since it has been demonstrated that E. coli RNAP and pLuxR genetic 
elements are compatible in the transcription of downstream genes135, the pLasRL was substituted 
with pLuxR in the synthetic 3OC12 HSL sensing device. NY009A contains LasR constitutively 
expressed by tet promoter and pLuxR behind GFP mut3b. However, the new genetic construct 
failed to sense 3OC12 HSL and no expression was detected upon the addition of the molecule 
(Fig. 4.28). 
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Fig. 4.28 3OC12 HSL did not activate protein expression from a pLuxR responsive promoter. 
NY009A was expressed in vitro with the S30 T7 high yield protein expression system at 37 °C. Kinetic 
experiments were monitored by fluorimetry for 6 h (ex 501 nm, em 511 nm). No protein expression was 
observed when 10 µM of 3OC12 HSL was added to the in vitro reaction (green circles). A negative control in 
the absence of 3OC12 HSL was performed (black circles). A cartoon above the graph gives a schematic 
representation of the used genetic circuit. 
 
Even if various promoters were tested, no success was obtained in the reconstruction of 
3OC12 HSL sensing device in vitro. However P. aeruginosa also contains a second quorum 
pathway made of RhlI and RhlR that responds to C4 HSL. rhlR was cloned downstream of the E. 
coli promoter J23119 while pRhlAB was used as a C4 HSL responsive promoter to control GFP 
mut3b expression. In P. aeruginosa, pRhlAB drives the expression of rhamnolipid synthesis genes 
and is activated by the C4 HSL-RhlR complex136. The synthetic C4 HSL sensing device (K575037) 
was expressed with a S30-T7 system in the presence and in the absence of the QS molecule. 
After 6 h at 37 ºC, GFP mut3b was produced at low levels both in the presence and in absence of 
C4 HSL, showing the lack of control of RhlR over transcription from pRhlAB (Fig. 4.29). 
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Fig. 4.29 C4 HSL did not activate protein expression from the pRhlAB responsive promoter. 
The synthetic C4 HSL sensing device was expressed with a S30 T7 high yield system in the presence and in 
the absence of 10 µM C4 HSL. No protein expression was observed when 10 µM of C4 HSL was added to 
the in vitro reaction (green circles) compared with negative control (black circles). Kinetic experiments were 
monitored by fluorimetry for 6 h (ex 501 nm, em 511 nm). A cartoon above the graph gives a schematic 
representation of the used genetic circuit. Data shown are from construct K575037. 
 
4.4.4 ΑHL artificial sender cells  
Although the in vitro reconstituted P. aeruginosa sensing systems failed to sense 3OC12 
HSL and C4 HSL, attempts were made to construct artificial cells able to synthesize and send 
ΑHLs.  LuxI-LuxR  QS  comprises  a  synthase  which  produces  ΑHL  molecules  starting  from  a  central  
metabolite SAM. The synthase interacts with a specific acyl carrier protein (ACP) loaded with the 
acyl chain of the specific length needed to synthetize the corresponding QS molecule. For 
example, SAM binds RhlI followed by butanoyl-ACP, an amide bond is formed between SAM and 
the acyl group, and both apo ACP and C4 HSL are released. In the same manner, LasI 
synthesizes 3OC12 HSL from SAM and acylated ACP.  
To produce in vitro 3OC12 HSL, a plasmid containing lasI under the control of a T7 
promoter (MC001A) was expressed with a S30 T7 high yield expression reaction containing 0.5 
mM  of  SAM.  To  monitor  the  production  of  the  ΑHL,  a  3OC12  HSL  E. coli reporter strain carrying 
the K575024 plasmid was built. The reporter strain was demonstrated to respond to 3OC12 HSL 
expressing GFP mut3b. After 6 h at 37 °C, the in vitro 3OC12 HSL synthesis reaction was added 
to the 3OC12 HSL reporter strain. The cells were incubated at 37 °C and every hour a few 
microliters were diluted in PBS and analyzed by flow cytometry. In the same manner a plasmid, 
named MC003A, containing rhlI synthase behind a T7 promoter was expressed with the S30 T7 
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high yield reaction to produce C4 HSL molecules in vitro, starting from SAM. To monitor the 
presence  of  ΑHL,  a  C4  HSL  E. coli reporter strain was engineered using the K575037 plasmid. 
The reporter cells express GFP mut3b only in the presence of C4 HSL. After 6 h of incubation of 
the reactions together with E. coli reporter strains, no green cells were found (Fig. 4.30). Both 
synthetic sending devices failed to produce 3OC12 HSL and C4 HSL.  
 
 
Fig. 4.30  ΑHLs  sending  devices  failed  to  produce  QS  molecules  in vitro. 
LasI and RhlI were expressed in vitro with a S30 T7 high yield protein expression system at 37 °C. Reactions 
were  mixed  together  with  the  corresponding  ΑHL  E. coli reporter strain and GFP expression was monitored 
by flow cytometry. No green positive cells were counted (green bars). Positive controls were performed by 
adding  0.1  µM  of  the  correspondent  ΑHL  to  E. coli (blue  bars).  No  ΑHLs  were  added  in  the  negative  controls  
(grey bars). Cartoons above the graph give a schematic representation of the used genetic constructs. Data 
shown are from MC001A and MC003A. 
 
To check whether the genetically encoded devices for 3OC12 HSL and C4 HSL were at 
least   able   to   produce   the   ΑHLs   molecules   in vivo, E. coli Bl21(DE3) were transformed with 
MC001A and MC003A. Cells were grown in LB until OD600 0.5 and harvested. The supernatant 
was  then  mixed  with  ΑHL  E. coli reporter strains and incubated at 37 ºC. Both 3OC12 HSL and C4 
HSL were successfully produced in vivo, with 40% and 45% of green positive cells counted 
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Fig. 4.31  ΑHLs  sending  device  were  functional  in vivo. 
LasI and RhlI were expressed in E. coli Bl21(DE3) . Cell-free culture fluids were added to the correspondent 
ΑHL  E. coli reporter strain and GFP expression was monitored by flow cytometry. 40% green events were 
counted for both E. coli expressing cells. Positive controls were performed by adding 0.1 µM of the 
correspondent  ΑHL  to  the  E. coli cells  (blue  bars).  No  ΑHLs  were  added  in  the  negative  controls  (grey  bars).  
Cartoons above the graph give a schematic representation of the used genetic constructs. Data shown are 
from MC001A and MC003A. 
 
Since  the  syntheses  of  ΑHLs  was  fully  functional   in vivo, it is possible that the cell-free E. 
coli extract used in the in vitro reaction lacked some of the components necessary to produce the 
ΑHLs.  Previous studies showed that the in vitro synthesis of C4-HSL molecules from purified RhlI 
and the appropriately charged coenzyme A derivative, n-butanoyl-CoA137. Thus, the in vitro 
production of QS molecules was tested with the addition of acetyl-CoA as precursor.  Reactions 
were performed as previously described, except for the addition of 100 µM acetyl-CoA. After 6 h at 
37 ºC, reactions were collected and added to the E. coli reporter strains. After overnight incubation 
at 37 ºC, the E. coli reporter strains were analyzed by flow cytometry.  The 3OC12 HSL reporter 
strain responded to 3OC12 HSL produced in vitro with a percentage of 50% of green positive cells, 
while C4 HSL reporter strain showed 87 % of green events (Fig. 4.32). Thanks to the presence of 
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Fig. 4.32  ΑHLs  sending  devices  produced  QS  molecules  in vitro when acetyl-CoA was added. 
LasI and RhlI were expressed in vitro with the S30 T7 high yield protein expression system at 37 °C together 
with 100 µM of acetyl-CoA.   Reactions   were  mixed   together   with   the   correspondent   ΑHL   E. coli reporter 
strain, and GFP expression was monitored by flow cytometry. A percentage of 50% and 90% of green 
positive cells were counted (green bars) for LasI and RhlI expressing reactions, respectively. Positive 
controls  were  performed  by  adding  0.1  µM  of   the  correspondent  ΑHL  to  E. coli cells  (blue  bars).  No  ΑHLs  
were added in the negative controls (grey bars). Cartoons above the graph give a schematic representation 
of the used genetic constructs. Data shown are from MC001A and MC003A. 
 
In  order   to  build  artificial  cells  able   to  synthesize  and  send  ΑHL  molecules,   the  next  step  
was to encapsulate the synthetic sender devices within phospholipid vesicles. Relying on previous 
results obtained with the AI-2 sender device, 1:2 POPC-cholesterol vesicles were rehydrated with 
T7 S30 E. coli cell extract supplemented with 300 µM of acetyl-CoA, 1 mM of SAM and 2 µg of 
MC001A or MC003A to produce C4 HSL or 3OC12 HSL, respectively. Protease K was added to 
the outside of the formed vesicles to avoid unwanted protein production. Vesicles were mixed with 
ΑHL  reporter  strains  at 37 ºC to allow the expression of the synthases, the production of the QS 
molecules and the resulting response of E. coli cells. Aliquots were analyzed by flow cytometry at 
various time points. Artificial cells were able to synthesize and send 3OC12 HSL, as shown in 
figure 4.33. 35% of green positive cells were recorded after 6 h of incubation. Instead, no signal 
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Fig. 4.33 3OC12 HSL artificial sender cells produced 3OC12 HSL. 
LasI and RhlI were encapsulated in phospholipid vesicles together with the S30 T7 high yield protein 
expression   system.   Artificial   cells   were   incubated   at   37   °C   together   with   the   correspondent   ΑHL   E. coli 
reporter strain and GFP expression was monitored by flow cytometry. 34% of green positive cells were 
counted in 3OC12 HSL artificial sender cells and no green events were observed with the artificial cells 
producing C4 HSL (green bars). Positive controls were performed by adding 0.1 µM of the correspondent 
ΑHL  to  E. coli cells  (blue  bars).  No  ΑHLs  were  added  to  the  negative  controls  (grey  bars).  Cartoons above 
the graph give a schematic representation of the used genetic constructs within vesicles. Data shown are 
from MC001A and MC003A. 
 
To test whether C4 HSL was produced inside of the artificial cells but failed to cross the 
phospholipid compartment, another reaction was set up. Vesicles were incubated alone at 37 °C to 
allow for the production of C4 HSL. Then the samples were divided and one aliquot was treated 
with sonication to disrupt the vesicles and release any C4 HSL molecules trapped inside. Samples 
were mixed together with C4 HSL E. coli reporter strain and incubated at 37 °C. No green cells 
were present in both treated and untreated samples (Fig. 4.34). In other words, the artificial cells 
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Fig. 4.34 C4 HSL artificial sender cells failed to produce C4 HSL. 
RhlI was encapsulated in phospholipid vesicles together with the S30 T7 high yield protein expression 
system.   After   6   h   of   incubation,   artificial   cells   were   mixed   together   with   the   correspondent   ΑHL   E. coli 
reporter strain and GFP expression was monitored by flow cytometry. No green positive events were found 
in both intact (green bar) or sonicated vesicles (dark green bar). Positive controls were performed by adding 
0.1  µM  of  the  correspondent  ΑHL  to  E. coli cells  (blue  bars).  No  ΑHLs  were  added  in  the  negative controls 
(grey bars). A cartoon above the graph gives a schematic representation of the used genetic construct within 
vesicles. Data shown are from MC003A. 
 
4.4.5 In vitro reconstruction of V. fischeri QS 
To build an in vitro V. fischeri QS device, a genetically encoded luxR gene was placed 
under a tet promoter to constitutively express the 3OC6 HSL receptor. To monitor the specific 
response, GFP mut3b was cloned downstream of pLuxR, a 3OC6 HSL responsive promoter. The 
pLuxR used here was composed of the lux box region of the intergenic region of the lux operon. 
The synthetic 3OC6 HSL sensing device, named T9002, was expressed with an E. coli S30 extract 
in the presence and in the absence of 10 µM 3OC6 HSL. Reactions were incubated at 37 °C and 
monitored for 6 h. Kinetic experiments showed the specific expression of GFP only in the presence 
of the V. fischeri ΑHL  molecule  (Fig. 4.35).   
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Fig. 4.35 3OC6 HSL activated protein expression in vitro. 
A synthetic 3OC6 HSL sensing device was expressed with a S30 E. coli cell extract at 37 °C. Kinetic 
experiments were monitored by fluorimetry for 6 h (ex 501 nm, em 511 nm). In the presence of 10 µM 3OC6 
HSL, the synthetic device expressed GFP mut3b (green circles), while no signal was observed when this QS 
molecule was absent (black circles). A cartoon above the graph gives a schematic representation of the 
used genetic circuit. Data shown are from construct T9002. 
 
The concentration of 3OC6 HSL used in the cell-free reaction was higher than the 
physiological concentration found in natural cells. Thus, the activity of the synthetic 3OC6 HSL 
system was tested also with lower amounts of the QS molecule. Reactions were set up as 
previously described except for the concentration of 3OC6 HSL, which varied from 10 µM to 0.1 
µM. All concentrations gave rise to the expression of the reporter gene (Fig. 4.36), showing that 
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Fig. 4.36 Natural concentrations of 3OC6 HSL activate protein expression in vitro. 
Fluorescent intensities after 6 h of expression of the 3OC6 HSL sensing part in vitro with a S30 E. coli cell 
extract at 37 °C. Different concentrations of 3OC6 HSL were added. 10 µM 3OC6 HSL activated protein 
expression (dark green bar). Both 1 µM and 0.1 µM activated protein expression (green and light blue bars, 
respectively). No 3OC6 HSL was added in the negative control (black bar). Kinetic experiments were 
monitored at CFX 96 Real-Time PCR machine for 6 h using SYBR green filter. A cartoon above the graph 
gives a schematic representation of the used genetic circuit. Data shown are from construct T9002. 
 
V. fischeri also contains a second QS system, which involves N-octanoyl-L-Homoserine 
lactone (C8 HSL) molecules138. C8 HSL is synthesized by AinS and binds LuxR with a lower 
affinity than 3OC6 HSL. Since C8 HSL is produced at low cell density it can bind LuxR and induce 
the production of 3OC6 HSL. A synthetic 3OC6 HSL sensing device was tested also in the 
presence of C8 HSL. However when T9002 was expressed with the S30 E. coli extract with 10 µM 
of C8 HSL, no protein production was detected, probably due to the lower affinity of this QS 
molecule for LuxR (Fig. 4.37). 
 
Fig. 4.37 C8 HSL failed to activate protein expression in vitro. 
A synthetic 3OC6 HSL sensing device was expressed with a S30 E. coli cell extract at 37 °C. Kinetic 
experiments were monitored by fluorimetry for 6 h (ex 501 nm, em 510 nm). In the presence of 10 µM C8 
HSL, no protein expression was observed (green circles). A cartoon above the graph gives a schematic 
representation of the used genetic circuit. Data shown are from construct T9002. 
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Greenberg139 showed how LuxR could be mutated to sense in vivo both 3OC6 HSL and C8 
HSL with high affinity, and the authors engineered a version of LuxR capable sensing only C8 
HSL. To assess if such LuxR variants could work in the same manner also in vitro, WT LuxR in 
T9002 was mutated. A first construct containing T33A S116A S135I LuxR was tested to sense 
both 3OC6 and C8 HSL within a cell-free reaction. GFP mut3b expression was activated in the 
presence  of  both  ΑHLs  without  background  signal  in  their absence (Fig. 4.38).  
 
Fig. 4.38 The T33A S116A S135I LuxR variant activates protein expression in response to 3OC6 HSL and 
C8 HSL. 
Fluorescent intensities after 6 h of expression of the LuxR variant sensing part in vitro with a S30 E. coli cell 
extract at 37 °C. Reactions were monitored at CFX 96 Real-Time PCR machine for 6 h using SYBR green 
filter. 10 µM 3OC6 HSL and C8 HSL were added. Both QS molecules could activate protein expression 
when T33A S116A S135I LuxR is used in the synthetic sensing device (green and dark green bars, 
respectively).  No  ΑHLs  were  added   in  the  negative  control  (black  bar).  A  cartoon above the graph gives a 
schematic representation of the used genetic circuit. Data shown are from construct RL086A. 
 
An additional mutation in LuxR causes the protein to lose the ability to sense 3OC6 HSL, 
and thus specifically respond to C8 HSL. T33A M65R S116A S135I LuxR was tested in vitro with a 
S30 E. coli cell extract with or without 3OC6 or C8 HSL. As showed in vivo, the LuxR mutant failed 
to recognize 3OC6 HSL and activated protein production in the presence of C8 HSL (Fig. 4.39). 
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Fig. 4.39 The T33A M65R S116A S135I LuxR variant activated protein expression only in the presence of 
C8 HSL. 
Fluorescent intensities after 6 h of expression of the LuxR variant sensing part in vitro with a S30 E. coli cell 
extract at 37 °C. 10 µM 3OC6 HSL and C8 HSL were added. C8 HSL activated protein expression (dark 
green  bar).   3OC6  HSL  was  not   recognized  by   the   LuxR  variant   (green  bar).  No  ΑHLs were added to the 
negative control (black bar). Reactions were monitored at CFX 96 Real-Time PCR machine for 6 h using 
SYBR green filter. A cartoon above the graph gives a schematic representation of the used genetic circuit. 
Data shown are from construct RL087A. 
 
Since the 3OC6 HSL synthetic sensing device successfully sensed V. fischeri QS 
molecules, the following step was to encapsulate the device inside a lipid compartment to build 
artificial cells that can sense living cells. First, the possibility of monitoring GFP production inside 
phospholipid vesicles was tested. 1:2 POPC: cholesterol vesicles were rehydrated with a plasmid 
encoded GFP mut3b under the control of a T7 promoter together with the S30 T7 high yield 
expression system. GFP production was monitored over time with a fluorimeter. No signal was 
detected after 6 h of incubation at 37 °C (Fig. 4.40).  
 
Fig. 4.40 GFP mut3b production inside phospholipid vesicles could not be detected with a fluorimeter. 
Kinetic profile of GFP mut3b expression with the S30 T7 high yield protein expression system inside of 
phospholipid vesicles (ex 501 nm, em 511 nm). No fluorescent signal was detected using a 
spectrofluorimeter to monitor GFP production. 
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Vesicles scatter light, leading to difficulties in monitoring the fluorescent signal. GFP 
expressing phospholipid vesicles were therefore next analyzed by flow cytometry. Vesicles were 
incubated at 37 °C and at different time points 2 µL were collected and analyzed by flow cytometry. 
The data revealed a small percentage (2%) of active vesicles (Fig. 4.41). 
 
Fig. 4.41 GFP mut3b production inside of phospholipid vesicles could not be detected by flow cytometry. 
Flow cytometry analysis of GFP mut3b expressed with the S30 T7 high yield protein expression system 
inside of phospholipid vesicles. No green positive events were counted. 
 
 To actively express GFP, vesicles need to contain all of the transcription-translation 
machinery components and a sufficient amount of plasmid DNA. The low amount of GFP 
expressing vesicles could be due to low encapsulation efficiency. To monitor artificial cells able to 
sense living cells, a stronger output signal was necessary. Instead of monitoring the production of 
a fluorescent protein, the enzyme luciferase could be used. In this way, once the enzyme is 
expressed it can continuously produce the signal. GFPmut3b in T9002 was then substituted with 
the firefly luciferase gene. 1:2 POPC: cholesterol vesicles were hydrated with RL082A and S30 E. 
coli cell extract. Formed vesicles were incubated at 37 °C for 5 h in the presence and in the 
absence of 10 µM 3OC6 HSL. After the reaction, ATP and luciferin were added as an energy 
source and a substrate for luciferase. Vesicles were broken with 0.3% Triton X-100 to allow 
luciferin to interact with the produced enzyme. Only in the presence of 3OC6 HSL in the external 
environment were vesicles found to produce the luciferase enzyme and emit light (Fig. 4.42).   
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Fig. 4.42 Artificial cells sense 3OC6 HSL. 
RL082A was encapsulated in 1:2 POPC: cholesterol vesicles together with a S30 E. coli cell extract. 10 µM 
of 3OC6 HSL was added to the external solution and vesicles were incubated at 37 °C for 5 h. 
Luminescence was monitored with a plate reader. Artificial cells sensed 3OC6 HSL and emitted light (light 
blue bar). No 3OC6 HSL was added to the negative control (black bar). A cartoon above the graph gives a 
schematic representation of the used genetic circuit. 
 
The artificial cells were able to sense 3OC6 HSL added to the outside of the compartment. 
The following step was to test whether artificial cells could sense living cells. Thus, a culture of V. 
fischeri was placed together artificial cells. At high cell density, V. fischeri releases in the outside 
3OC6 HSL and emits light itself. Since also artificial cells emit light in the presence of 3OC6 HSL, 
the bacteria were separated from the vesicles (artificial cells) so that only light produced from the 
artificial cells was detected. A V. fischeri culture at OD 1.2 was placed on one side of a dialysis 
apparatus, while 1:2 POPC: cholesterol vesicles containing RL082A and S30 E. coli cell extract 
were inserted on the other side. In this manner, 3OC6 HSL produced by V. fischeri could freely 
diffuse through the membrane and reach the artificial cells, but bacteria cannot cross the 
membrane. After 5 h of incubation, the artificial cells were removed from the dialysis apparatus, 
broken with Triton X-100, and ATP and luciferin were added. The artificial cells successfully 
sensed the 3OC6 HSL produced from V. fischeri and emitted light only in the presence of the 
bacteria (Fig. 4.43).  
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Fig. 4.43 Artificial cells sense V. fischeri. 
a) A graphic representation of the experiment performed. In the presence of V. fischeri, artificial cells sense 
3OC6 HSL and emit light through luciferase expression. b) A cartoon gives a schematic representation of the 
used genetic circuit inside artificial cells (RL82A). c) RL082A was encapsulated in 1:2 POPC: cholesterol 
vesicles together with a S30 E. coli cell extract. Artificial cells were incubated with a culture of V. fischeri for 5 
h. Luminescence was monitored with a plate reader. Artificial cells sensed 3OC6 HSL from V. fischeri and 
emitted light (light blue bar). Vesicles were incubated with LBS in the negative control (black bar). d) A 
scheme of the dialysis apparatus used in the experiments. V. fischeri is separated from artificial cells through 
a 20 kDa membrane. The membrane does not allow the transit of bacterial cells, whereas 3OC6 HSL 
produced from V. fischeri can freely cross the membrane and reach the artificial cells. 
 
V. fischeri produces 3OC6 HSL through LuxI synthase, starting from SAM and acyl-ACP. 
To construct artificial cells able to synthesize and release 3OC6 HSL, the luxI gene was cloned 
into pET21b. The construct named MC002A expressed LuxI behind a T7 promoter. As previously 
described, first the activity of LuxI was tested when expressed with the S30 T7 high yield 
expression system. MC002A was added to the reaction together with SAM and acetyl-CoA and 
incubated for 6 h at 37 °C. The reaction was stopped and mixed together with a 3OC6 HSL E. coli 
reporter strain. The reporter strain carried the plasmid T9002 and produced GFPmut3b only in the 
presence of 3OC6 HSL. The mixture was left overnight at 37 °C and monitored by flow cytometry. 
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Fig. 4.44 3OC6 HSL sender device produced 3OC6 HSL in vitro. 
LuxI was expressed in vitro with the S30 T7 high yield protein expression system at 37 °C together with 100 
µM of acetyl-CoA. Reactions were mixed together with the correspondent 3OC6 HSL E. coli reporter strain, 
and GFP expression was monitored by flow cytometry. A percentage of 95% was counted (green bar). 
Positive controls were performed by adding 0.1 µM of 3OC6 HSL to E. coli (blue bar). No molecule was 
added in the negative controls (grey bar). A cartoon above the graph gives a schematic representation of the 
used genetic construct. Data shown are from MC002A. 
 
The 3OC6 HSL in vitro sending device was then encapsulated into 1:2 POPC: cholesterol 
vesicles. Frozen vesicle aliquots were rehydrated with MC002A, S30 T7 high yield expression 
system, SAM and acetyl-CoA. Protease K was added to the outside of the formed vesicles 
(artificial cells) and the artificial cells were mixed with a 3OC6 HSL E. coli reporter strain. Few 
microliters were analyzed by flow cytometry at different time points to monitor 3OC6 HSL 
production. After 6 h, artificial cells were able to synthesize and send 3OC6 HSL to E. coli cells 
with almost 90% of green positive events recorded (Fig. 4.45). 
 
 
Fig. 4.45 3OC6 HSL artificial sender cells produced 3OC6 HSL. 
LuxI was encapsulated in phospholipid vesicles together with the S30 T7 high yield protein expression 
system. Artificial cells were incubated at 37 °C with a 3OC6 HSL E. coli reporter strain, and GFP expression 
was monitored by flow cytometry. 90% of green positive cells were counted with the 3OC6 HSL artificial 
sender cells (green bar). Positive controls were performed by adding 0.1 µM of 3OC6 HSL to E. coli cells 
(blue  bar).  No  ΑHLs  were  added   to   the  negative  controls (grey bars). A cartoon above the graph gives a 
schematic representation of the used genetic construct within vesicles. Data shown are from MC002A. 
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4.4.6 Mixing together artificial and natural cells 
Artificial sensor cells able to sense living cells through QS and artificial sender cells able to 
synthesize and send QS molecules to living cells were successfully built. To integrate the artificial 
cells together with living cells it is necessary assess whether living bacteria can be mixed with the 
artificial systems without interference or damage. For example, P. aeruginosa is a pathogen known 
to produce phospholipases, toxins and biosurfactants140 which could break the phospholipid 
compartment. Thus, a dye leakage assay was used to test the resistance of phospholipid vesicles 
when placed together with bacteria. The lipid film was rehydrated with 10 mM calcein to form 
vesicles. After homogenization and overnight tumbling, the vesicles were loaded onto a sepharose 
4b column to remove non-encapsulated dye. Purified vesicles were then mixed 1:1 with bacterial 
culture and monitored by fluorimetry. If the bacteria could break the phospholipid membrane, 
calcein would be released, resulting in an increased fluorescence signal due to diminished self-
quenching. 
Since 1:2 POPC: cholesterol vesicles gave the best results in the previous experiments, 
this same lipid composition was tested together with different bacterial strains. When vesicles were 
placed in contact with V. fischeri cells, no increment of signal was detected within 10 h of 
incubation (Fig. 4.46). V. fischeri does not release lipolytic factors and, therefore, does not seem 
able to break phospholipid vesicles. As a control, Triton X-100 was added after 10 h, resulting in 
immediate breaking of the vesicles and an increment of fluorescence.  
 
Fig. 4.46 V. fischeri did not damage phospholipid vesicles. 
Fluorescent profile of 1:2 POPC: cholesterol vesicles containing 10 mM calcein in buffer A (50  mM  HEPES,  
10  mM   MgCl2,   100  mM   KCl,   pH   7.6) were mixed with a culture of V. fischeri. Fluorescent signal was 
monitored by fluorimetry (ex 495 nm, em 515 nm) at 28 °C. After 10 h, no breakage was observed in 
phospholipid vesicle. 
 
1:2 POPC: vesicles were then mixed with P. aeruginosa PA14 cells. As shown in figure 
4.47, a slow but constant increase of signal was detected, meaning that the bacteria secreted 
factors that could break the phospholipid membrane resulting in 20% of lysis within 4 h. 
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Fig. 4.47 P. aeruginosa damages phospholipid vesicles. 
Fluorescent profile of 1:2 POPC: cholesterol vesicles containing 10 mM calcein in buffer A (50  mM  HEPES,  
10  mM  MgCl2,  100  mM  KCl,  pH  7.6) were mixed with a culture of P. aeruginosa. Vesicles were monitored for 
10 h by fluorimetry (ex 495 nm, em 515 nm) at 37 °C. P. aeruginosa damaged the phospholipid membrane 
of the vesicles and calcein was released to the outside. 
 
Since P. aeuroginosa was able to easily destroy 1:2 POPC: cholesterol membranes other 
lipid compositions were tested to find vesicles resistant to pathogens. P. aeruginosa secretes 
phospholipases which target phosphatidylcholine,141 thus vesicles of 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[amino(polyethylene glycol)-5000] DSPE-PEG(5000) with 1,2-dioleoyl-sn-
glycero-3-phospho-(1'-rac-glycerol) (DOPG) were made. Phosphatidylethanolamine (PE) and 
phosphatidylglycerol (PG) are the major components of Gram-negative inner membranes142 and 
should serve as substrates to the lytic enzymes of Pseudomonas. The polyethylene glycol lipid 
conjugate DSPE-PEG(5000) should protect the membrane of the vesicle by creating a steric 
barrier around the vesicle, potentially inhibiting phospholipid hydrolysis143. Thus, the higher 
concentration of PEG possible to not preclude vesicles formation was used. 9:1 DOPG: DSPE 
PEG vesicles were then incubated with P. aeruginosa cells. However, 10% of PEG conjugate lipid 
was not sufficient to avoid vesicles breakage (Fig. 4.48). 
 
Fig. 4.48 1:9 DOPG: DSPE PEG vesicles were damaged by P. aeruginosa cells. 
Fluorescent profile of 9:1 DOPG: DSPE PEG vesicles containing 10 mM calcein in buffer A (50  mM  HEPES,  
10  mM  MgCl2,  100  mM  KCl,  pH  7.6) mixed with P. aeruginosa culture. Vesicles were monitored for 10 h by 
fluorimetry at 37 °C (ex 495 nm, em 515 nm). PEG coated vesicles were destroyed by the pathogen. The 
increment in fluorescence is due to the release of calcein in the outside. 
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Pseudomonas recognizes the long chain fatty acids moiety of phospholipids as an 
attractant, and the phospholipases are active against such lipids144. Therefore, vesicles composed 
of lipids of a different structure, i.e. sphingomyelin, were tested. Unfortunately, P. aeruginosa was 
able to break also vesicles made with this composition (Fig. 4.49). 
 
Fig. 4.49 P. aeruginosa destroyed sphingomyelin vesicles. 
Fluorescent profile of sphingomyelin vesicles containing 10 mM calcein in buffer A (50  mM  HEPES,  10  mM  
MgCl2,   100  mM   KCl,   pH   7.6) mixed with P. aeruginosa culture. Vesicles were monitored for 10 h by 
fluorimetry at 37 °C (ex 495 nm, em 515). Vesicles broke when in contact with P. aeruginosa. 
 
Several PA14 mutants were then used to assess whether deleting phospholipase genes would 
result in a more stable bacterial - vesicle system. Sphingomyelin vesicles were mixed together with 
various PA14 single mutants and monitored for 10 h. No improvements in vesicles stability were 
observed for any of the PA14 mutants (Fig. 4.50), and no Pseudomonas resistant lipid 
compositions were found.  
  
Fig. 4.50 P. aeruginosa PA14 mutants destroyed sphingomyelin vesicles. 
Fluorescent profile of sphingomyelin vesicles containing 10 mM calcein in buffer A (50  mM  HEPES,  10  mM 
MgCl2,  100  mM  KCl,  pH  7.6) when mixed with different P. aeruginosa PA14 single mutants. Vesicles were 
monitored for 10 h at 37 °C by fluorimetry (ex 495 nm, em 515 nm). Vesicles were destroyed by all the P. 
aeruginosa mutants tested. 
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The results obtained so far demonstrated that the construction of artificial cells able to 
sense V. fischeri, and artificial cells able to synthesize and send various QS molecules for V. 
fischeri, E. coli, V. harveyi and P. aeruginosa are possible. The next step was to join together the 
sensing and sending devices to build a complete communication pathway between the artificial 
and bacterial cells. To better understand if artificial cells could sense a QS molecule and respond 
by producing a QS molecule, two different QS systems were placed together within the artificial 
cells. 
First, a synthetic circuit able to sense V. fischeri and send a message to E. coli or V. 
harveyi through AI-2 was set up. GFP cloned into T9002 was replaced with the HLTP module in 
order to produce AI-2 in response to 3OC6 HSL. The synthetic device, named JF008A, was then 
tested in solution using a S30 E. coli cell extract expression system. Reactions were set up as 
previously described, adding 0.5 mM of SAH precursor with or without 10 µM of 3OC6 HSL, and 
incubated at 37 °C for 6 h. Different methods were then exploited to monitor AI-2 production. To 
measure V. harveyi response to AI-2, 10 µL of reactions were added to 90 µL of V. harveyi BB170 
reporter strain and luminescence was monitored after 4 h. No differences were observed between 
samples incubated with or without 3OC6 HSL (Fig. 4.51), and both samples resulted in very low 
luminesce output.  
  
Fig. 4.51 Synthetic 3OC6 HSL sensing AI-2 sending circuit failed to elicit a response in V. harveyi. 
JF008A was expressed in vitro with a S30 E. coli cell extract at 37 °C in the presence and in the absence of 
3OC6 HSL. Samples mixed with the V. harveyi BB170 reporter strain did not elicit luminescence in the 
reporter strain when 3OC6 HSL was present in the reaction (light blue bar). 50 µM of AI-2 was added to the 
reporter strain as a positive control (blue bar). A cartoon above the graph gives a schematic representation 
of the used genetic circuit. 
 
The presence of AI-2 could be measured also through flow cytometry exploiting an AI-2 E. 
coli reporter strain. The strain cannot produce its own AI-2, because of the lack of a functional luxS 
gene, and this strain was engineered to sense external autoinducer and express GFPuv in 
response. Reactions were set up as previously described and mixed with E. coli after 6 h. At 
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different time points a few microliters of cells were collected and analyzed by flow cytometry. No 
GFP positive cells were counted after 6 h of incubation (Fig. 4.52).  
 
Fig. 4.52 Synthetic 3OC6 HSL sensing AI-2 sending circuit failed to elicit a response with an AI-2 E. coli 
reporter strain. 
JF008A was expressed in vitro with a S30 E. coli cell extract at 37 °C in the presence and in the absence of 
3OC6 HSL. Samples were mixed with the AI-2 E. coli reporter strain and monitored by flow cytometry. No 
green positive events were counted when 3OC6 HSL was present (green bar) or absent (black bar) in the 
reaction. 50 µM AI-2 was added to E. coli as a positive control (blue bar). LB was added as a negative 
control (grey bar). A cartoon above the graph gives a schematic representation of the used genetic circuit. 
 
Both V. harveyi and E. coli reporter strains for AI-2 are not optimized to measured small 
amounts of autoinducer and to discriminate between small differences in concentrations. The V. 
harveyi bioassay is known to be more qualitative than quantitative,126 and the reporter gene, 
GFPuv, is not optimal for flow cytometry. That is because the excitation wavelength of GFPuv (395 
nm) is not highly compatible with the FITC filter of the flow cytometer. To quantify the response of 
the E. coli cells to AI-2, a RT-qPCR assay was exploited. AI-2 is known to activate transcription of 
the lsr operon, thus overexpression of lsrACDB genes was monitored in the presence of AI-2. Cell-
free reactions expressing JF008A in the presence and in the absence of 3OC6 HSL were added to 
the E. coli reporter strain. After 6 h of incubation, E. coli was harvested and the RNA was extracted 
and retrotranscribed. RT-qPCR analysis showed no overexpression of lsr genes when 3OC6 HSL 
was added (Fig. 4.53).  
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Fig. 4.53 Synthetic 3OC6 HSL sensing, AI-2 sending circuit failed to elicit a response in E. coli. 
JF008A was expressed in vitro with the S30 E. coli extract at 37 °C in the presence and in the absence of 
3OC6 HSL. Samples were mixed with AI-2 E. coli reporter strain. No overexpression of lsrACBD genes was 
observed by qPCR in the presence of 3OC6 HSL (green bars) compared to samples in which 3OC6 HSL 
was absent (black bars). 50 µM AI-2 was added to E. coli as a positive control (blue bar), and LB was added 
as negative control (grey bar). A cartoon above the graph gives a schematic representation of the used 
genetic circuit. 
 
To understand if AI-2 was being produced at low concentrations without reaching the 
necessary amount to elicit a response from the bacteria, AI-2 was quantified by using 2,2'-dinitro-
5,5'-ditiodibenzoico (DTNB). After 6 h at 37 °C, the cell-free expression reactions were stopped 
and chloroform extracted to remove the proteins. Samples were then added to the DTNB reagent 
and measured by UV-VIS spectroscopy. No differences were observed between the samples 
incubated with or without 3OC6 HSL (Fig. 4.54). 
 
Fig. 4.54 Synthetic 3OC6 HSL sensing AI-2 sending circuit failed to produce AI-2. 
JF008A was expressed in vitro with a S30 E. coli cell extract at 37 °C for 6 h in the presence and in the 
absence of 10 µM 3OC6 HSL. Reactions were then chloroform extracted to remove proteins. Purified 
reactions were added 1:100 to DTNB solution and AI-2 was quantified. No differences were observed in the 
presence and in the absence of 3OC6 HSL (light blue and black bars, respectively). A cartoon above the 
graph gives a schematic representation of the used genetic circuit. 
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Even if the sensing and the sending parts worked as separate units, when joined together 
the synthetic circuit failed to synthesize AI-2 in response to 3OC6 HSL. Other than AI-2, artificial 
cells were able to synthesize and send P. aeruginosa QS molecules. Therefore, the 3OC6 HSL 
sensing module was joined with either 3OC12 HSL or C4 HSL sending devices. Similarly, for 
HLPT, the gene coding for GFP in T9002 was replaced with lasI or rhlI genes. 
RL080A contains luxR constitutively expressed from a tet promoter and rhlI controlled by 
the 3OC6 HSL responsive promoter pLuxR. This synthetic device produces C4 HSL in response to 
3OC6 HSL. Reactions expressing RL080A with a S30 E. coli cell extract were incubated with or 
without 1 µM 3OC6 HSL for 6 h at 37 °C. Samples were then added to C4 HSL the E. coli reporter 
strain and analyzed by flow cytometry at different time points. After 10 h, the cells showed 70% 
and 0.1% of green positive events when incubated with or without 3OC6 HSL, respectively (Fig. 
4.55). A control in which 1 µM of 3OC6 HSL was directly added to the C4 HSL reporter strain was 
performed in order to exclude GFP expression due to unspecific recognition of 3OC6 HSL instead 
of C4 HSL. The control sample gave rise to 25 % of green positive events, meaning that a lower 
percentage of positive cells in the positive reaction sample derived from 3OC6 HSL added to 
activate C4 HSL production.  
 
Fig. 4.55 A synthetic 3OC6 HSL sensing, C4 HSL sending circuit elicits a response in an E. coli reporter 
strain. 
RL080A was expressed in vitro with a S30 E. coli cell extract at 37 °C in the presence and in the absence of 
3OC6 HSL. Samples were mixed with the C4 HSL E. coli reporter strain and monitored by flow cytometry. 70 
% of green positive events were counted when 3OC6 HSL was present in the reaction (green bar). No GFP 
expression was observed in the absence of 3OC6 HSL (black bar). 0.1 µM C4 HSL was added to E. coli as a 
positive control (blue bar). LB was added as a negative control (grey bar). A cartoon above the graph gives a 
schematic representation of the used genetic circuit. 
 
RL080A and S30 E. coli cell extracts were then encapsulated within phospholipid vesicles 
to build artificial cells able to sense 3OC6 HSL and produce C4 HSL. Vesicles were mixed 1:1 with 
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the C4 HSL E. coli reporter strain and incubated at 37 °C with or without 3OC6 HSL added to the 
outside of the artificial cells. After 16 h of monitoring, no difference in percentage of positive GFP 
cells were counted by flow cytometry between samples containing artificial cells and control 
reactions for 3OC6 HSL (Fig. 4.56). As previously shown for the C4 HSL sending part, when the 
reaction was encapsulated inside of the lipid compartments the amount of C4 HSL produced by 
the artificial cells was not enough to elicit a response from the bacteria. 
 
Fig. 4.56 Artificial cells were not able to produce C4 HSL in response to 3OC6 HSL. 
A S30 E. coli cell extract supplemented with RL080A, SAM and acetyl-CoA were encapsulated in 
phospholipid vesicles. a) A graphic representation of the experiment performed. In the absence of 3OC6 
HSL no reaction occurs inside artificial cell. When 3OC6 HSL is added outside, artificial cell senses the 
molecule and synthesizes C4 HSL. E. coli responds to C4 HSL expressing GFP. b) A cartoon gives a 
schematic representation of the used genetic circuit inside artificial cells (RL080A). c) Artificial cells were 
incubated with the C4 HSL E. coli reporter strain and monitored by flow cytometry. No difference in the 
percentage of green positive events were observed when 1 µM 3OC6 HSL was added to the artificial cells 
(green bar) or directly to the E. coli cells as control (red bar). 0.1 µM C4 HSL was added to E. coli as a 
positive control (blue bar). LB was added as a negative control (grey bar).  
 
However, as shown above, artificial cells can produce the other P. aeruginosa QS 
molecule, 3OC12 HSL. In RL079A, the 3OC6 HSL-LuxR complex controls LasI expression and 
thus 3OC12 HSL production. First, this circuit was tested with the S30 E. coli cell extract system 
plus or minus the addition of 3OC6 HSL. After 6 h at 37 °C, the reactions were mixed together with 
the 3OC12 HSL E. coli reporter strain. After 6 h 50 % of positive events were found upon the 
addition of 3OC6 HSL, while less than 1% of GFP expressing cells were observed in the negative 
reaction (Fig. 4.57). 
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Fig. 4.57 A synthetic 3OC6 HSL sensing, 3OC12 HSL sending circuit elicits a response from the E. coli 
reporter strain. 
RL079A was expressed in vitro with a S30 E. coli cell extract at 37 °C in the presence and in the absence of 
1 µM 3OC6 HSL. Samples were mixed with the 3OC6 HSL E. coli reporter strain and monitored by flow 
cytometry. 50 % of green positive events were counted when 3OC6 HSL was present in the reaction (green 
bar). No GFP expression was present in the absence of 3OC6 HSL (black bar). 0.1 µM 3OC12 HSL was 
added to E. coli as a positive control (blue bar). LB was added as a negative control (grey bar). 4 % of 
positive events were counted in the sample where 1 µM 3OC6 HSL was added directly to the reporter strain 
to check for unspecific fluorescence (red bar). A cartoon above the graph gives a schematic representation 
of the used genetic circuit. 
 
The next step was to encapsulate the reaction inside of 1:2 POPC: cholesterol vesicles. 
Reactions were set up as previously described for the C4 HSL module. After 10 h almost 40 % of 
positive cells were counted upon the addition of 1 µM 3OC6 HSL to the exterior of the artificial 
cells. No positive cells were present in the negative control (Fig. 4.58).  
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Fig. 4.58 Artificial cells produce 3OC12 HSL in response to 3OC6 HSL. 
A S30 E. coli extract supplemented with RL079A, SAM and acetyl-CoA were encapsulated in phospholipid 
vesicles. a) A graphic representation of the experiment performed. In the absence of 3OC6 HSL no reaction 
occurs inside artificial cell. When 3OC6 HSL is added outside, artificial cell senses the molecule and 
synthesizes 3OC12 HSL. E. coli responds to 3OC12 HSL expressing GFP. b) A cartoon gives a schematic 
representation of the used genetic circuit inside artificial cells (RL79A). c) Artificial cells were incubated with 
the 3OC12 HSL E. coli reporter strain and monitored by flow cytometry.  33 % of green positive events were 
counted when 3OC6 HSL was added to the artificial cells (green bar). No GFP expression was observed in 
the absence of 3OC6 HSL (black bar). 0.1 µM 3OC12 HSL was added to E. coli as a positive control (blue 
bar). LB was added as a negative control (grey bar). 2 % of positive events were counted in samples where 
1 µM 3OC6 HSL was added directly to the reporter strain to check for unspecific fluorescence (red bar). 
 
Artificial cells were able to sense 3OC6 HSL and in response synthesize 3OC12 HSL, 
eliciting a response in E. coli. However, 3OC6 HSL was added to the outside of the vesicles. To 
set up a communication path between two different bacterial strains, the artificial cells need to 
sense directly the presence of the living cells. Therefore, artificial cells expressing RL079A were 
incubated with V. fischeri grown until OD 1.2. To avoid the counting of V. fischeri cells by flow 
cytometry, a dialysis apparatus was set up. Artificial cells and E. coli were placed on the top of a 
dialysis cap while the V. fischeri culture was put on the other side of a 20 kDa membrane. 3OC6 
HSL produced by V. fischeri could freely cross the membrane and activate 3OC12 HSL production 
in the artificial cells. Upon the release of 3OC12 HSL from the artificial cells, E. coli expresses 
GFPmut3b. As a negative control, the V. fischeri culture was substituted with LBS medium. 
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Positive control contained LBS supplement with 0.1 µM of 3OC12 HSL. Also, a control in which the 
E. coli reporter strain and empty vesicles were incubated with the V. fischeri culture was performed 
to monitor GFP expression due to 3OC6 HSL instead of 3OC12 HSL. Reactions were incubated at 
28 °C to facilitate the growth of V. fischeri. Every 2 h a few microliters of E. coli were collected and 
analyzed by flow cytometry. After 14 h the E. coli cells incubated with artificial cells and V. fischeri 
resulted in more than 30 % of positive green cells (Fig. 4.59). No positive events were found in 
negative control reaction, while 10 % of unspecific GFP production was recorded in the control 
sample. 
 
Fig. 4.59 Artificial cells sense V. fischeri and produce 3OC12 HSL, eliciting a response from the E. coli 
reporter strain. 
a) A graphic representation of the experiment performed. In the absence of V. fischeri no reaction occurs 
inside artificial cell. When mixed with V. fischeri, artificial cells sense 3OC6 HSL and synthesize 3OC12 HSL. 
E. coli responds to 3OC12 HSL expressing GFP. b) A cartoon gives a schematic representation of the used 
genetic circuit inside artificial cells (RL79A). c) Artificial cells expressing RL079A were incubated with V. 
fischeri at 28 °C and the 3OC12 HSL E. coli reporter strain. Reporter cells were monitored by flow cytometry. 
After 14 h, the artificial cells sensed 3OC6 HSL from V. fischeri and sent 3OC12 HSL to the E. coli reporter 
strain, which showed 28 % of green positive events (green bar). No positive events were counted in the 
negative control where the artificial cells were incubated with LBS (black bar). 0.1 µM 3OC12 HSL was 
added to E. coli as a positive control (blue bar). LB was added as a negative control (grey bar). 10 % of 
positive events were counted in samples where 1 µM 3OC6 HSL was added directly to the reporter strain to 
test for unspecific fluorescence (red bar). d) A scheme of the dialysis apparatus used in the experiments. V. 
fischeri is separated from E. coli reporter strain and artificial cells from a 20 kDa membrane. The membrane 
does not allow the transit of bacterial cells, whereas 3OC6 HSL produced from V. fischeri can freely cross 
the membrane and reach the artificial cells. 
 
Unfortunately, these results were difficult to replicate. Changes in encapsulation efficiency 
could lead to minimal 3OC12 HSL production and consequently a poor response from the E. coli 
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reporter cells. Reaction conditions were then optimized to improve 3OC12 HSL production. For 
example, in the previous experiments, reactions were incubated at 28 °C to favor the growth of V. 
fischeri. However, 28 °C is not the optimal temperature for the S30 E. coli cell extract to work 
efficiently. Moreover, 3OC6 HSL was produced on one side of the dialysis apparatus, and the 
molecule had to cross the membrane to equilibrate the concentration across the compartments. 
The process was likely slow and therefore 3OC6 HSL may have reached the artificial cells when 
the transcription-translation machinery within the artificial cells was no longer active. Thus, V. 
fischeri was grown until OD 1.2 and placed in the dialysis apparatus on the other side. 50 µL of LB 
was inserted in the dialysis cap. Samples were left at room temperature for 2 h to allow 3OC6 HSL 
to equally distribute between the two compartments. Artificial cells and E. coli were then added to 
the dialysis cap, and the reactions were incubated at 37 °C. At different time points a few 
microliters were collected and measured by flow cytometry. After 8 h, more than 40 % of the cells 
were positive in the sample in which the artificial cells were incubated with V. fischeri (Fig. 4.60).  
 
Fig. 4.60 Under optimal conditions artificial cells sense V. fischeri and produce 3OC12 HSL, eliciting a 
greater response from the E. coli reporter strain. 
a) A graphic representation of the experiment performed. In the absence of V. fischeri no reaction occurs 
inside artificial cell. When mixed with V. fischeri, artificial cells sense 3OC6 HSL and synthesize 3OC12 HSL. 
E. coli responds to 3OC12 HSL expressing GFP. b) A cartoon gives a schematic representation of the used 
genetic circuit inside artificial cells (RL79A). c) Artificial cells expressing RL079A were incubated with V. 
fischeri at 37 °C and the 3OC12 HSL E. coli reporter strain. V. fischeri was pre-incubated with LB for 2 h at 
room temperature. Reporter cells were monitored by flow cytometry. After 8 h, the artificial cells sensed 
3OC6 HSL from V. fischeri and sent 3OC12 HSL to the E. coli reporter strain, which showed 40 % of green 
positive events (green bar). No positive events were counted in the negative control where artificial cells 
were incubated with LBS (black bar). 0.1 µM 3OC12 HSL was added to E. coli as a positive control (blue 
bar). LB was added as a negative control (grey bar). 2 % of positive events were counted in samples where 
1 µM 3OC6 HSL was added directly to the reporter strain to test for unspecific fluorescence (red bar). d) A 
scheme of the dialysis apparatus used in the experiments. V. fischeri is separated from E. coli reporter strain 
and artificial cells from a 20 kDa membrane. Bacterial cells cannot transit the membrane, whereas 3OC6 
HSL produced from V. fischeri can freely cross the membrane and reach the artificial cells. 
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Artificial cells could successfully mediate the communication between two different bacterial 
strains that naturally cannot interact with each other through QS. 
 
4.5 Conclusions 
To better integrate artificial with natural cells, it is not sufficient for the artificial system to 
send messages to control the behavior of the living cells. What is needed is also a system able to 
sense and respond to living cells in order to establish a complete communication cycle. To reach 
this goal it could be possible to take advantage of the natural QS processes that bacteria use to 
communicate with each other. By reconstructing in vitro various QS pathways deriving from 
different bacteria, artificial cells that mimic bacterial communication were built. Similar artificial 
systems could be functionally adopted together with living cells. First artificial cells able to sense 
the presence of living cells were constructed. Then artificial cells capable of synthesizing and 
releasing various QS molecules to E. coli, V. harveyi, V. fischeri and P. aeruginosa were built. 
Finally, artificial cells that mediate interspecies communication were shown to be functional. 
However, the complete, two-way communication cycle was thus far only built with artificial cells 
and engineered E. coli. Future experiments will be set up in order to substitute the E. coli reporter 
strain with P. aeruginosa to demonstrate that artificial cells can mediate communication with 
natural and not genetically modified cells. Moreover, the artificial cells can sense and send the 
same QS molecule (3OC6 HSL from V. fischeri). Therefore, we will also attempt to integrate 
artificial cells within a single bacterial population in order to determine if living cells are able to 
distinguish between artificial and natural cells. This approach could lead to a new way to evaluate 
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Chapter 5.  
Conclusions  
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The work presented in this dissertation describes the construction of artificial cells able to 
integrate with natural cells. Synthetic biology mainly relies on the genetic engineering of living 
cells. Natural cells are genetically modified to acquire new functions. While useful, such an 
approach could lead to several complications. The addition of new and complex genetic circuits 
within living cells has to face the fact that multiple elements inside of cells are still unknown. This 
could lead to the loss of function of the new circuits. Moreover, living cells grow and evolve. The 
implementation of new behaviors could lead to consequences on the cellular environment and alter 
the ecosystem. A way to avoid such difficulties is represented by cell-free synthetic biology. The 
construction of artificial cells with known purified components will help to avoid some of the 
uncertainty associated with living cells. Artificial cells built in this work exploited phospholipids (as a 
compartment to divide the inside and the outside), transcription-translation machinery (either from 
a cell-free extract or from minimal purified components in PURE system), and DNA (as genetic 
information). Synthetic circuits built to obtain a certain function in artificial cells were made with 
various biological parts, joined together to construct several genetic circuits. To reach the 
construction of artificial cells with useful activity, a preliminary study on how to combine genetic 
elements within synthetic circuits was performed. Many efforts were made on the characterization 
of biological parts and in the functionality of a great variety of de novo constructed genetic circuits 
in vivo. However, the implementation of such systems in a cell-free chassis was difficult. Simple 
and clear rules were defined at the beginning of this work to build genetic circuits that function with 
in vitro transcription-translation systems. For example, not all fluorescent proteins are suitable in 
cell-free chassis, and the way genetic circuits are assembled together could strongly influence their 
functionality in artificial cells. Just the use of a wrong sequence between two genes inside the 
same synthetic operon can result in minimal protein expression. Following the rules developed in 
this part of the dissertation, many genetic circuits needed for the construction of the artificial cells 
were optimized to control protein expression levels. 
Next, efforts were made to construct artificial cells that are able to send messages to living 
cells. The following of such an approach moves the genetic engineering from living to artificial 
cells. The artificial system is built to carry out a specific function. After its action, the artificial 
system vanishes and natural cells resume to their original state. Such system does not have the 
possibility to evolve and mutate, avoiding long-term consequences. The work presented showed 
the possibility to control living cells through communication with artificial cells. Extant cells 
developed several pathways to sense their surroundings and modify their behavior to adapt to 
changes in the external environment. Thus, natural pathways can be exploited to control natural 
cells through communication with artificial cells. The artificial cells built in this study sense a 
molecule that Escherichia coli cannot sense on its own and translate it to a message that E. coli 
can sense. The artificial cells sense theophylline, which activates the expression of a pore forming 
protein, alpha hemolysin (αHL). αHL forms pores in the membrane of the artificial cells, and so 
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encapsulated IPTG is released. The ability of artificial cells to communicate with E. coli was 
assessed through the expression of GFP in E. coli receiver cells. Next, the ability of the artificial 
cells to elicit a transcriptional response in non-engineered E. coli was tested by monitoring 
expression from the lac operon. The result is that the natural ability of E. coli to sense small 
molecules was expanded without genetic intervention. Moreover, this work demonstrated the 
integration between natural and artificial systems and the construction of a one-way 
communication.  
Artificial cells can be better integrated with natural cells through the construction of an 
artificial system able to sense and respond to natural cells. Such a system not only needs to send 
messages to living cells but also to sense them. Bacteria communicate with each other through 
quorum sensing (QS). Small diffusible molecules are sensed and produced from bacterial cells. 
Through such system, bacteria can sense the presence of other bacteria and determine an overall 
population count. When the cellular density is high enough, the bacteria begin to act as a 
coordinated population. Many processes are regulated by QS, such as biofilm formation, virulence 
and bioluminescence. In this work we described an attempt to build a synthetic QS within artificial 
cells to integrate artificial and natural cells. Many sensing pathways were tested in vitro; however, 
only the Vibrio fischeri QS pathway was found to be functional in vitro. Nevertheless, artificial 
sender cells were successfully built to synthesize several QS molecules starting from their 
precursors. Artificial cells were capable of sending autoinducer 2 (AI-2) for E. coli and Vibrio 
harveyi, N-(3-oxododecanoyl)-L-homoserine lactone (3OC12 HSL) and N-butanoyl-L-homoserine 
(C4 HSL) for Pseudomonas aeruginosa and N-3-(oxohexanoyl)homoserine lactone (3OC6 HSL) 
for V. fischeri. Finally, sensing and sending devices were joined together in a complete system 
within artificial cells. The resulting combinations of parts were tested by using E. coli reporter 
strains responsive to each QS molecules produced by the artificial cells in response to V. fischeri. 
Artificial cells were able to sense V. fischeri and to synthesize 3OC12 HSL. Thus, a complete 
communication module between one bacterial population, the artificial cells and a second bacterial 
population was successfully established. The subsequent step will be the substitution of the E. coli 
reporter strain with P. aeruginosa to assess a complete communication between two non-
engineered bacterial populations through the artificial cells.   
The artificial systems built in this study exploited an E. coli extract to provide the cell-free 
transcription-translation machinery. While functional, cellular extracts contain unknown 
components which leads to an incomplete understanding of the functionality of the synthetic 
system. To better construct a minimal system made of known components, other transcription-
translation systems could be used. The PURE system is a cell-free system which allows for protein 
expression. The machinery is based on T7 RNA polymerase and is composed only of known, 
purified components. Our first attempts made with the PURE system failed to produce the AI-2 
molecule. Since the PURE system lacks molecular chaperones, it is possible that HLPT did not 
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fold properly when expressed with the PURE system. Also, the genetic circuits designed to detect 
the AHLs could not use the PURE system, because the AHL responsive promoters used in the 
genetic devices were not recognized by T7 polymerase. Additionally, the production of AHL 
molecules requires the presence of acetylated ACP. In the artificial cells, the synthesis of AHLs 
starts from acetyl-CoA, which is a substrate of protein enzymes involved in fatty acid elongation to 
charge the ACPs. Therefore, to exploit the PURE system, modifications of the system would be 
needed. For example, for the synthesis of AHLs, purified acetylated ACPs could be used and a 
promoter cascade in which T7 polymerase is produced in response to AHLs could be implemented 
in the genetic circuit.   
 
5.1 Future perspective 
The construction of a communication pathway mediated by the artificial cells could be used 
as a therapeutic tool to defeat pathogenic infections. P. aeruginosa is an opportunistic pathogen 
that colonizes the lungs of cystic fibrosis patient. QS in this species mediates biofilm formation that 
counteracts the effect of antibiotics, making it difficult to eradicate the pathogen, which ultimately 
leads to the death of the patient145. Several studies developed seek-and-destroy bacteria to 
eradicate infection;146, 147 however, these methods require the administration of engineered 
bacteria to the patient. The use of artificial cells capable of the same function would lead to a safer 
therapeutic. P. aeruginosa virulence genes are controlled both by QS molecules and growth 
related factors148. The artificial cells can be built to sense and release QS molecules when bacteria 
population has not reached yet the optimal cell density for biofilm formation. This would lead to the 
formation of disaggregate and incomplete biofilm structures that would be easier to disrupt. It has 
been shown that several bacteria naturally produce enzymes to destroy QS molecules of other 
species149. For example, Bacillus species are known to produce Aiia, an AHL lactonase, which 
hydrolyzes the homoserine lactone ring of both short and long acyl chain AHLs150, such as C4 HSL 
and 3OC12 HSL. Other bacteria are known to produce AHL acylase which hydrolyze the amide 
bond of AHLs producing fatty acids and homoserine lactone151. Artificial cells could be built to 
express such enzymes in response to pathogens and attenuate QS. In this manner, QS molecules 
can cross the phospholipid membrane and be degraded by the enzymes produced inside the 
vesicles. Moreover, several studies focused on the synthesis of QS molecule analogs80, 152, and so 
artificial cells could respond to pathogen by synthesizing and releasing such inhibitors of QS. 
Recently, Carbonell et al.153 developed a web-based pathway analysis platform based on 
retrosynthesis154 to search for biochemical transformations needed to obtain a specific compound 
starting from the chosen molecule to synthesize. The platform searches for all possible pathways 
found in diverse organisms that can be functional imported into the E. coli chassis. Such a tool 
could be used to determine which enzymes and precursors are needed to construct the synthetic 
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pathway within artificial cells composed, in part, by an E. coli cell extract. A different approach 
could be represented by targeting the P. aeruginosa outer membrane protein lectins. These 
proteins, in particular lectin A and B, present fucose and galactose binding sites involved in the 
binding of the pathogen to the epithelium155. Recent studies showed how the administration of 
fucose and galactose can diminish adhesion and thus biofilm formation, blocking the binding sites 
of lectins156, 157 . Artificial cells containing fucose and galactose could be constructed to release 
sugars through αHL   expression in the presence of AHLs.  We experienced much difficulty in 
constructing an in vitro AI-2 sensing device. However, LsrK was functional in vitro. LsrK is a kinase 
involved in the AI-2 pathway that phosphorylates AI-2 to phospho AI-2.  A recent study showed158 
how the external presence of LsrK decreases biofilm formation in E. coli through its natural 
function. When AI-2 is released from E. coli, it is phosphorylated by the external LsrK to phospho 
AI-2, and phosphorylated AI-2 cannot be taken up by E. coli. A similar system could be 
implemented with artificial cells. AI-2 is permeable to phospholipid vesicles. LsrK and ATP would 
be retained within and protected by the compartment, which could act as a delivery system. 
Phospho AI-2 produced inside the artificial cells could be used to activate the production of pore 
forming proteins to release the phosphorylated molecule to the outside. In this way, the action of 
LsrK would be dependent on the presence of E. coli.  
The functionality of the artificial cells as QS molecule senders was demonstrated. In 
addition to promoting biofilm formation, QS molecules also act as chemoattractants for bacteria159. 
Thus, artificial systems could also be used to control bacterial behavior by targeting motility 
pathways. The bacterial population could be forced to move and to concentrate in a specific area. 
Such a possibility could be exploited in environment for remediation. Artificial cells could attract oil 
eating bacteria, for example, to sites of contamination. Subsequently, the artificial cells would 
degrade, and the ecosystem would return to normality.     
On the other hand, the integration of artificial cells within natural cells represents a new way 
to evaluate how life-like artificial chemical systems are. The construction of artificial cells able to 
sense V. fischeri through 3OC6 HSL, and the ability of artificial cells to synthesize the same QS 
molecules were demonstrated. The union of such sensing and sending systems allows for 
communication between artificial cells natural bacteria. Bacteria use the QS process to recognize 
themselves. The presence of a certain amount of AHLs in the surrounding means for the cells the 
presence of their counterparts. From the reception of such signals, bacterial behavior dramatically 
changes. The living cell stops its behavior as single unit and starts acting as part of a coordinated 
population. The switch leads to a series of modifications in gene expression which are translated 
into several biological processes. Targeting such mechanisms through the activity of artificial cells 
able to mimic QS processes could be a strategy to construct an artificial system that is perceived 
as living by the bacteria. Due to the variety of processes that could derive from the communication 
between artificial cells and bacteria through 
 117  
are possible, from luminescence output to gene expression. We could then ask if the living cells 
are able to distinguish between the natural and artificial cells. Such an experiment would be 
conceptually similar to the way the Turing test is used to evaluate the intelligence of a machine. A 
cellular Turing test may give us a new angle from which to approach the boundary between living 
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mCerulean! 6182! 121.6! 0.030!
Cerulean! 5843! 88.8! 0.042!
GFPuv! 9632! 125.5! 0.026!
TJSapphire! 40919! 226.0! 0.025!
eGFP! 2136! 88.5! 0.032!
GFP! 1765! 120.0! 0.024!
sfGFP! 27714! 91.7! 0.038!
GFPmut3b! 15967! 78.7! 0.040!
mVenus! 37556! 103.6! 0.031!
Venus! 51874! 116.6! 0.036!
mYPet! 48637! 118.5! 0.036!
YPet! 51212! 149.3! 0.034!
TagRFPJT! 1838! 370.0! 0.013!
mRFP1! 1981! 171.2! 0.035!
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16S rRNA: 3'-   AUUCCUCCA.........-5'
RL027A:   5'-...UAAGGAGAAUAAUCUAUG-3'
0
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Supplementary information: Integrating artificial with natural cells to translate chemical messages 
that direct E. coli behavior. 
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RL069A T7 promoter,  
theophylline 
riboswitch, 
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Table 1. DNA sequences used in chapter 4. 
 
NAME  NOTE SEQUENCE* 
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GGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG 




















































































































MC001A pT7 RBS 



























MC003A pT7 RBS 













































RL028K pT7  
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ACCCTGCCCTTTTTCTTTAAAACCGAAAAGATTACTTCGCGT 

































































































































RL060K pT7 RBS 
lsrR RBS 











































































RL061K pT7 TTG 























































































































































































































































































































































































































































































































































   
 
*Promoters are underlined, start and stop codons are in bold, the RBS is in italics, and linker 
sequences in fusion proteins are in lowercase. lrs intergenic regions and its variants are in red.  
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